CINXE.COM
Financial Statements | Alnylam Pharmaceuticals, Inc.
<!DOCTYPE html> <html lang="en" dir="ltr" prefix="content: http://purl.org/rss/1.0/modules/content/ dc: http://purl.org/dc/terms/ foaf: http://xmlns.com/foaf/0.1/ og: http://ogp.me/ns# rdfs: http://www.w3.org/2000/01/rdf-schema# schema: http://schema.org/ sioc: http://rdfs.org/sioc/ns# sioct: http://rdfs.org/sioc/types# skos: http://www.w3.org/2004/02/skos/core# xsd: http://www.w3.org/2001/XMLSchema# "> <head> <meta charset="utf-8" /><script type="text/javascript">(window.NREUM||(NREUM={})).init={ajax:{deny_list:["bam.nr-data.net"]}};(window.NREUM||(NREUM={})).loader_config={licenseKey:"NRJS-ee2a76a7d3f7daf91d9",applicationID:"434717936"};;/*! For license information please see nr-loader-rum-1.274.0.min.js.LICENSE.txt */ (()=>{var e,t,r={8122:(e,t,r)=>{"use strict";r.d(t,{a:()=>i});var n=r(944);function i(e,t){try{if(!e||"object"!=typeof e)return(0,n.R)(3);if(!t||"object"!=typeof t)return(0,n.R)(4);const r=Object.create(Object.getPrototypeOf(t),Object.getOwnPropertyDescriptors(t)),o=0===Object.keys(r).length?e:r;for(let a in o)if(void 0!==e[a])try{if(null===e[a]){r[a]=null;continue}Array.isArray(e[a])&&Array.isArray(t[a])?r[a]=Array.from(new Set([...e[a],...t[a]])):"object"==typeof e[a]&&"object"==typeof t[a]?r[a]=i(e[a],t[a]):r[a]=e[a]}catch(e){(0,n.R)(1,e)}return r}catch(e){(0,n.R)(2,e)}}},2555:(e,t,r)=>{"use strict";r.d(t,{Vp:()=>c,fn:()=>s,x1:()=>u});var n=r(384),i=r(8122);const o={beacon:n.NT.beacon,errorBeacon:n.NT.errorBeacon,licenseKey:void 0,applicationID:void 0,sa:void 0,queueTime:void 0,applicationTime:void 0,ttGuid:void 0,user:void 0,account:void 0,product:void 0,extra:void 0,jsAttributes:{},userAttributes:void 0,atts:void 0,transactionName:void 0,tNamePlain:void 0},a={};function s(e){try{const t=c(e);return!!t.licenseKey&&!!t.errorBeacon&&!!t.applicationID}catch(e){return!1}}function c(e){if(!e)throw new Error("All info objects require an agent identifier!");if(!a[e])throw new Error("Info for ".concat(e," was never set"));return a[e]}function u(e,t){if(!e)throw new Error("All info objects require an agent identifier!");a[e]=(0,i.a)(t,o);const r=(0,n.nY)(e);r&&(r.info=a[e])}},9417:(e,t,r)=>{"use strict";r.d(t,{D0:()=>g,gD:()=>h,xN:()=>p});var n=r(993);const i=e=>{if(!e||"string"!=typeof e)return!1;try{document.createDocumentFragment().querySelector(e)}catch{return!1}return!0};var o=r(2614),a=r(944),s=r(384),c=r(8122);const u="[data-nr-mask]",d=()=>{const e={mask_selector:"*",block_selector:"[data-nr-block]",mask_input_options:{color:!1,date:!1,"datetime-local":!1,email:!1,month:!1,number:!1,range:!1,search:!1,tel:!1,text:!1,time:!1,url:!1,week:!1,textarea:!1,select:!1,password:!0}};return{ajax:{deny_list:void 0,block_internal:!0,enabled:!0,harvestTimeSeconds:10,autoStart:!0},distributed_tracing:{enabled:void 0,exclude_newrelic_header:void 0,cors_use_newrelic_header:void 0,cors_use_tracecontext_headers:void 0,allowed_origins:void 0},feature_flags:[],generic_events:{enabled:!0,harvestTimeSeconds:30,autoStart:!0},harvest:{tooManyRequestsDelay:60},jserrors:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},logging:{enabled:!0,harvestTimeSeconds:10,autoStart:!0,level:n.p_.INFO},metrics:{enabled:!0,autoStart:!0},obfuscate:void 0,page_action:{enabled:!0},page_view_event:{enabled:!0,autoStart:!0},page_view_timing:{enabled:!0,harvestTimeSeconds:30,autoStart:!0},performance:{capture_marks:!1,capture_measures:!1},privacy:{cookies_enabled:!0},proxy:{assets:void 0,beacon:void 0},session:{expiresMs:o.wk,inactiveMs:o.BB},session_replay:{autoStart:!0,enabled:!1,harvestTimeSeconds:60,preload:!1,sampling_rate:10,error_sampling_rate:100,collect_fonts:!1,inline_images:!1,fix_stylesheets:!0,mask_all_inputs:!0,get mask_text_selector(){return e.mask_selector},set mask_text_selector(t){i(t)?e.mask_selector="".concat(t,",").concat(u):""===t||null===t?e.mask_selector=u:(0,a.R)(5,t)},get block_class(){return"nr-block"},get ignore_class(){return"nr-ignore"},get mask_text_class(){return"nr-mask"},get block_selector(){return e.block_selector},set block_selector(t){i(t)?e.block_selector+=",".concat(t):""!==t&&(0,a.R)(6,t)},get mask_input_options(){return e.mask_input_options},set mask_input_options(t){t&&"object"==typeof t?e.mask_input_options={...t,password:!0}:(0,a.R)(7,t)}},session_trace:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},soft_navigations:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},spa:{enabled:!0,harvestTimeSeconds:10,autoStart:!0},ssl:void 0,user_actions:{enabled:!0}}},l={},f="All configuration objects require an agent identifier!";function g(e){if(!e)throw new Error(f);if(!l[e])throw new Error("Configuration for ".concat(e," was never set"));return l[e]}function p(e,t){if(!e)throw new Error(f);l[e]=(0,c.a)(t,d());const r=(0,s.nY)(e);r&&(r.init=l[e])}function h(e,t){if(!e)throw new Error(f);var r=g(e);if(r){for(var n=t.split("."),i=0;i<n.length-1;i++)if("object"!=typeof(r=r[n[i]]))return;r=r[n[n.length-1]]}return r}},3371:(e,t,r)=>{"use strict";r.d(t,{V:()=>f,f:()=>l});var n=r(8122),i=r(384),o=r(6154),a=r(9324);let s=0;const c={buildEnv:a.F3,distMethod:a.Xs,version:a.xv,originTime:o.WN},u={customTransaction:void 0,disabled:!1,isolatedBacklog:!1,loaderType:void 0,maxBytes:3e4,onerror:void 0,ptid:void 0,releaseIds:{},appMetadata:{},session:void 0,denyList:void 0,timeKeeper:void 0,obfuscator:void 0},d={};function l(e){if(!e)throw new Error("All runtime objects require an agent identifier!");if(!d[e])throw new Error("Runtime for ".concat(e," was never set"));return d[e]}function f(e,t){if(!e)throw new Error("All runtime objects require an agent identifier!");d[e]={...(0,n.a)(t,u),...c},Object.hasOwnProperty.call(d[e],"harvestCount")||Object.defineProperty(d[e],"harvestCount",{get:()=>++s});const r=(0,i.nY)(e);r&&(r.runtime=d[e])}},9324:(e,t,r)=>{"use strict";r.d(t,{F3:()=>i,Xs:()=>o,xv:()=>n});const n="1.274.0",i="PROD",o="CDN"},6154:(e,t,r)=>{"use strict";r.d(t,{OF:()=>c,RI:()=>i,WN:()=>d,bv:()=>o,gm:()=>a,mw:()=>s,sb:()=>u});var n=r(1863);const i="undefined"!=typeof window&&!!window.document,o="undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self.navigator instanceof WorkerNavigator||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis.navigator instanceof WorkerNavigator),a=i?window:"undefined"!=typeof WorkerGlobalScope&&("undefined"!=typeof self&&self instanceof WorkerGlobalScope&&self||"undefined"!=typeof globalThis&&globalThis instanceof WorkerGlobalScope&&globalThis),s=Boolean("hidden"===a?.document?.visibilityState),c=/iPad|iPhone|iPod/.test(a.navigator?.userAgent),u=c&&"undefined"==typeof SharedWorker,d=((()=>{const e=a.navigator?.userAgent?.match(/Firefox[/\s](\d+\.\d+)/);Array.isArray(e)&&e.length>=2&&e[1]})(),Date.now()-(0,n.t)())},1687:(e,t,r)=>{"use strict";r.d(t,{Ak:()=>c,Ze:()=>l,x3:()=>u});var n=r(7836),i=r(3606),o=r(860),a=r(2646);const s={};function c(e,t){const r={staged:!1,priority:o.P3[t]||0};d(e),s[e].get(t)||s[e].set(t,r)}function u(e,t){e&&s[e]&&(s[e].get(t)&&s[e].delete(t),g(e,t,!1),s[e].size&&f(e))}function d(e){if(!e)throw new Error("agentIdentifier required");s[e]||(s[e]=new Map)}function l(e="",t="feature",r=!1){if(d(e),!e||!s[e].get(t)||r)return g(e,t);s[e].get(t).staged=!0,f(e)}function f(e){const t=Array.from(s[e]);t.every((([e,t])=>t.staged))&&(t.sort(((e,t)=>e[1].priority-t[1].priority)),t.forEach((([t])=>{s[e].delete(t),g(e,t)})))}function g(e,t,r=!0){const o=e?n.ee.get(e):n.ee,s=i.i.handlers;if(!o.aborted&&o.backlog&&s){if(r){const e=o.backlog[t],r=s[t];if(r){for(let t=0;e&&t<e.length;++t)p(e[t],r);Object.entries(r).forEach((([e,t])=>{Object.values(t||{}).forEach((t=>{t[0]?.on&&t[0]?.context()instanceof a.y&&t[0].on(e,t[1])}))}))}}o.isolatedBacklog||delete s[t],o.backlog[t]=null,o.emit("drain-"+t,[])}}function p(e,t){var r=e[1];Object.values(t[r]||{}).forEach((t=>{var r=e[0];if(t[0]===r){var n=t[1],i=e[3],o=e[2];n.apply(i,o)}}))}},7836:(e,t,r)=>{"use strict";r.d(t,{P:()=>c,ee:()=>u});var n=r(384),i=r(8990),o=r(3371),a=r(2646),s=r(5607);const c="nr@context:".concat(s.W),u=function e(t,r){var n={},s={},d={},l=!1;try{l=16===r.length&&(0,o.f)(r).isolatedBacklog}catch(e){}var f={on:p,addEventListener:p,removeEventListener:function(e,t){var r=n[e];if(!r)return;for(var i=0;i<r.length;i++)r[i]===t&&r.splice(i,1)},emit:function(e,r,n,i,o){!1!==o&&(o=!0);if(u.aborted&&!i)return;t&&o&&t.emit(e,r,n);for(var a=g(n),c=h(e),d=c.length,l=0;l<d;l++)c[l].apply(a,r);var p=m()[s[e]];p&&p.push([f,e,r,a]);return a},get:v,listeners:h,context:g,buffer:function(e,t){const r=m();if(t=t||"feature",f.aborted)return;Object.entries(e||{}).forEach((([e,n])=>{s[n]=t,t in r||(r[t]=[])}))},abort:function(){f._aborted=!0,Object.keys(f.backlog).forEach((e=>{delete f.backlog[e]}))},isBuffering:function(e){return!!m()[s[e]]},debugId:r,backlog:l?{}:t&&"object"==typeof t.backlog?t.backlog:{},isolatedBacklog:l};return Object.defineProperty(f,"aborted",{get:()=>{let e=f._aborted||!1;return e||(t&&(e=t.aborted),e)}}),f;function g(e){return e&&e instanceof a.y?e:e?(0,i.I)(e,c,(()=>new a.y(c))):new a.y(c)}function p(e,t){n[e]=h(e).concat(t)}function h(e){return n[e]||[]}function v(t){return d[t]=d[t]||e(f,t)}function m(){return f.backlog}}(void 0,"globalEE"),d=(0,n.Zm)();d.ee||(d.ee=u)},2646:(e,t,r)=>{"use strict";r.d(t,{y:()=>n});class n{constructor(e){this.contextId=e}}},9908:(e,t,r)=>{"use strict";r.d(t,{d:()=>n,p:()=>i});var n=r(7836).ee.get("handle");function i(e,t,r,i,o){o?(o.buffer([e],i),o.emit(e,t,r)):(n.buffer([e],i),n.emit(e,t,r))}},3606:(e,t,r)=>{"use strict";r.d(t,{i:()=>o});var n=r(9908);o.on=a;var i=o.handlers={};function o(e,t,r,o){a(o||n.d,i,e,t,r)}function a(e,t,r,i,o){o||(o="feature"),e||(e=n.d);var a=t[o]=t[o]||{};(a[r]=a[r]||[]).push([e,i])}},3878:(e,t,r)=>{"use strict";function n(e,t){return{capture:e,passive:!1,signal:t}}function i(e,t,r=!1,i){window.addEventListener(e,t,n(r,i))}function o(e,t,r=!1,i){document.addEventListener(e,t,n(r,i))}r.d(t,{DD:()=>o,jT:()=>n,sp:()=>i})},5607:(e,t,r)=>{"use strict";r.d(t,{W:()=>n});const n=(0,r(9566).bz)()},9566:(e,t,r)=>{"use strict";r.d(t,{LA:()=>s,bz:()=>a});var n=r(6154);const i="xxxxxxxx-xxxx-4xxx-yxxx-xxxxxxxxxxxx";function o(e,t){return e?15&e[t]:16*Math.random()|0}function a(){const e=n.gm?.crypto||n.gm?.msCrypto;let t,r=0;return e&&e.getRandomValues&&(t=e.getRandomValues(new Uint8Array(30))),i.split("").map((e=>"x"===e?o(t,r++).toString(16):"y"===e?(3&o()|8).toString(16):e)).join("")}function s(e){const t=n.gm?.crypto||n.gm?.msCrypto;let r,i=0;t&&t.getRandomValues&&(r=t.getRandomValues(new Uint8Array(e)));const a=[];for(var s=0;s<e;s++)a.push(o(r,i++).toString(16));return a.join("")}},2614:(e,t,r)=>{"use strict";r.d(t,{BB:()=>a,H3:()=>n,g:()=>u,iL:()=>c,tS:()=>s,uh:()=>i,wk:()=>o});const n="NRBA",i="SESSION",o=144e5,a=18e5,s={STARTED:"session-started",PAUSE:"session-pause",RESET:"session-reset",RESUME:"session-resume",UPDATE:"session-update"},c={SAME_TAB:"same-tab",CROSS_TAB:"cross-tab"},u={OFF:0,FULL:1,ERROR:2}},1863:(e,t,r)=>{"use strict";function n(){return Math.floor(performance.now())}r.d(t,{t:()=>n})},944:(e,t,r)=>{"use strict";function n(e,t){"function"==typeof console.debug&&console.debug("New Relic Warning: https://github.com/newrelic/newrelic-browser-agent/blob/main/docs/warning-codes.md#".concat(e),t)}r.d(t,{R:()=>n})},5284:(e,t,r)=>{"use strict";r.d(t,{t:()=>c,B:()=>s});var n=r(7836),i=r(6154);const o="newrelic";const a=new Set,s={};function c(e,t){const r=n.ee.get(t);s[t]??={},e&&"object"==typeof e&&(a.has(t)||(r.emit("rumresp",[e]),s[t]=e,a.add(t),function(e={}){try{i.gm.dispatchEvent(new CustomEvent(o,{detail:e}))}catch(e){}}({loaded:!0})))}},8990:(e,t,r)=>{"use strict";r.d(t,{I:()=>i});var n=Object.prototype.hasOwnProperty;function i(e,t,r){if(n.call(e,t))return e[t];var i=r();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,t,{value:i,writable:!0,enumerable:!1}),i}catch(e){}return e[t]=i,i}},6389:(e,t,r)=>{"use strict";function n(e,t=500,r={}){const n=r?.leading||!1;let i;return(...r)=>{n&&void 0===i&&(e.apply(this,r),i=setTimeout((()=>{i=clearTimeout(i)}),t)),n||(clearTimeout(i),i=setTimeout((()=>{e.apply(this,r)}),t))}}function i(e){let t=!1;return(...r)=>{t||(t=!0,e.apply(this,r))}}r.d(t,{J:()=>i,s:()=>n})},5289:(e,t,r)=>{"use strict";r.d(t,{GG:()=>o,sB:()=>a});var n=r(3878);function i(){return"undefined"==typeof document||"complete"===document.readyState}function o(e,t){if(i())return e();(0,n.sp)("load",e,t)}function a(e){if(i())return e();(0,n.DD)("DOMContentLoaded",e)}},384:(e,t,r)=>{"use strict";r.d(t,{NT:()=>o,US:()=>d,Zm:()=>a,bQ:()=>c,dV:()=>s,nY:()=>u,pV:()=>l});var n=r(6154),i=r(1863);const o={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net"};function a(){return n.gm.NREUM||(n.gm.NREUM={}),void 0===n.gm.newrelic&&(n.gm.newrelic=n.gm.NREUM),n.gm.NREUM}function s(){let e=a();return e.o||(e.o={ST:n.gm.setTimeout,SI:n.gm.setImmediate,CT:n.gm.clearTimeout,XHR:n.gm.XMLHttpRequest,REQ:n.gm.Request,EV:n.gm.Event,PR:n.gm.Promise,MO:n.gm.MutationObserver,FETCH:n.gm.fetch,WS:n.gm.WebSocket}),e}function c(e,t){let r=a();r.initializedAgents??={},t.initializedAt={ms:(0,i.t)(),date:new Date},r.initializedAgents[e]=t}function u(e){let t=a();return t.initializedAgents?.[e]}function d(e,t){a()[e]=t}function l(){return function(){let e=a();const t=e.info||{};e.info={beacon:o.beacon,errorBeacon:o.errorBeacon,...t}}(),function(){let e=a();const t=e.init||{};e.init={...t}}(),s(),function(){let e=a();const t=e.loader_config||{};e.loader_config={...t}}(),a()}},2843:(e,t,r)=>{"use strict";r.d(t,{u:()=>i});var n=r(3878);function i(e,t=!1,r,i){(0,n.DD)("visibilitychange",(function(){if(t)return void("hidden"===document.visibilityState&&e());e(document.visibilityState)}),r,i)}},3434:(e,t,r)=>{"use strict";r.d(t,{YM:()=>c});var n=r(7836),i=r(5607);const o="nr@original:".concat(i.W);var a=Object.prototype.hasOwnProperty,s=!1;function c(e,t){return e||(e=n.ee),r.inPlace=function(e,t,n,i,o){n||(n="");const a="-"===n.charAt(0);for(let s=0;s<t.length;s++){const c=t[s],u=e[c];d(u)||(e[c]=r(u,a?c+n:n,i,c,o))}},r.flag=o,r;function r(t,r,n,s,c){return d(t)?t:(r||(r=""),nrWrapper[o]=t,function(e,t,r){if(Object.defineProperty&&Object.keys)try{return Object.keys(e).forEach((function(r){Object.defineProperty(t,r,{get:function(){return e[r]},set:function(t){return e[r]=t,t}})})),t}catch(e){u([e],r)}for(var n in e)a.call(e,n)&&(t[n]=e[n])}(t,nrWrapper,e),nrWrapper);function nrWrapper(){var o,a,d,l;try{a=this,o=[...arguments],d="function"==typeof n?n(o,a):n||{}}catch(t){u([t,"",[o,a,s],d],e)}i(r+"start",[o,a,s],d,c);try{return l=t.apply(a,o)}catch(e){throw i(r+"err",[o,a,e],d,c),e}finally{i(r+"end",[o,a,l],d,c)}}}function i(r,n,i,o){if(!s||t){var a=s;s=!0;try{e.emit(r,n,i,t,o)}catch(t){u([t,r,n,i],e)}s=a}}}function u(e,t){t||(t=n.ee);try{t.emit("internal-error",e)}catch(e){}}function d(e){return!(e&&"function"==typeof e&&e.apply&&!e[o])}},993:(e,t,r)=>{"use strict";r.d(t,{ET:()=>o,p_:()=>i});var n=r(860);const i={ERROR:"ERROR",WARN:"WARN",INFO:"INFO",DEBUG:"DEBUG",TRACE:"TRACE"},o="log";n.K7.logging},3969:(e,t,r)=>{"use strict";r.d(t,{TZ:()=>n,XG:()=>s,rs:()=>i,xV:()=>a,z_:()=>o});const n=r(860).K7.metrics,i="sm",o="cm",a="storeSupportabilityMetrics",s="storeEventMetrics"},6630:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewEvent},782:(e,t,r)=>{"use strict";r.d(t,{T:()=>n});const n=r(860).K7.pageViewTiming},6344:(e,t,r)=>{"use strict";r.d(t,{G4:()=>i});var n=r(2614);r(860).K7.sessionReplay;const i={RECORD:"recordReplay",PAUSE:"pauseReplay",REPLAY_RUNNING:"replayRunning",ERROR_DURING_REPLAY:"errorDuringReplay"};n.g.ERROR,n.g.FULL,n.g.OFF},4234:(e,t,r)=>{"use strict";r.d(t,{W:()=>o});var n=r(7836),i=r(1687);class o{constructor(e,t){this.agentIdentifier=e,this.ee=n.ee.get(e),this.featureName=t,this.blocked=!1}deregisterDrain(){(0,i.x3)(this.agentIdentifier,this.featureName)}}},7603:(e,t,r)=>{"use strict";r.d(t,{j:()=>P});var n=r(860),i=r(2555),o=r(3371),a=r(9908),s=r(7836),c=r(1687),u=r(5289),d=r(6154),l=r(944),f=r(3969),g=r(384),p=r(6344);const h=["setErrorHandler","finished","addToTrace","addRelease","addPageAction","setCurrentRouteName","setPageViewName","setCustomAttribute","interaction","noticeError","setUserId","setApplicationVersion","start",p.G4.RECORD,p.G4.PAUSE,"log","wrapLogger"],v=["setErrorHandler","finished","addToTrace","addRelease"];var m=r(1863),b=r(2614),y=r(993);var w=r(2646),A=r(3434);function R(e,t,r,n){if("object"!=typeof t||!t||"string"!=typeof r||!r||"function"!=typeof t[r])return(0,l.R)(29);const i=function(e){return(e||s.ee).get("logger")}(e),o=(0,A.YM)(i),a=new w.y(s.P);return a.level=n.level,a.customAttributes=n.customAttributes,o.inPlace(t,[r],"wrap-logger-",a),i}function E(){const e=(0,g.pV)();h.forEach((t=>{e[t]=(...r)=>function(t,...r){let n=[];return Object.values(e.initializedAgents).forEach((e=>{e&&e.api?e.exposed&&e.api[t]&&n.push(e.api[t](...r)):(0,l.R)(38,t)})),n.length>1?n:n[0]}(t,...r)}))}const x={};function _(e,t,g=!1){t||(0,c.Ak)(e,"api");const h={};var w=s.ee.get(e),A=w.get("tracer");x[e]=b.g.OFF,w.on(p.G4.REPLAY_RUNNING,(t=>{x[e]=t}));var E="api-",_=E+"ixn-";function N(t,r,n,o){const a=(0,i.Vp)(e);return null===r?delete a.jsAttributes[t]:(0,i.x1)(e,{...a,jsAttributes:{...a.jsAttributes,[t]:r}}),j(E,n,!0,o||null===r?"session":void 0)(t,r)}function T(){}h.log=function(e,{customAttributes:t={},level:r=y.p_.INFO}={}){(0,a.p)(f.xV,["API/log/called"],void 0,n.K7.metrics,w),function(e,t,r={},i=y.p_.INFO){(0,a.p)(f.xV,["API/logging/".concat(i.toLowerCase(),"/called")],void 0,n.K7.metrics,e),(0,a.p)(y.ET,[(0,m.t)(),t,r,i],void 0,n.K7.logging,e)}(w,e,t,r)},h.wrapLogger=(e,t,{customAttributes:r={},level:i=y.p_.INFO}={})=>{(0,a.p)(f.xV,["API/wrapLogger/called"],void 0,n.K7.metrics,w),R(w,e,t,{customAttributes:r,level:i})},v.forEach((e=>{h[e]=j(E,e,!0,"api")})),h.addPageAction=j(E,"addPageAction",!0,n.K7.genericEvents),h.setPageViewName=function(t,r){if("string"==typeof t)return"/"!==t.charAt(0)&&(t="/"+t),(0,o.f)(e).customTransaction=(r||"http://custom.transaction")+t,j(E,"setPageViewName",!0)()},h.setCustomAttribute=function(e,t,r=!1){if("string"==typeof e){if(["string","number","boolean"].includes(typeof t)||null===t)return N(e,t,"setCustomAttribute",r);(0,l.R)(40,typeof t)}else(0,l.R)(39,typeof e)},h.setUserId=function(e){if("string"==typeof e||null===e)return N("enduser.id",e,"setUserId",!0);(0,l.R)(41,typeof e)},h.setApplicationVersion=function(e){if("string"==typeof e||null===e)return N("application.version",e,"setApplicationVersion",!1);(0,l.R)(42,typeof e)},h.start=()=>{try{(0,a.p)(f.xV,["API/start/called"],void 0,n.K7.metrics,w),w.emit("manual-start-all")}catch(e){(0,l.R)(23,e)}},h[p.G4.RECORD]=function(){(0,a.p)(f.xV,["API/recordReplay/called"],void 0,n.K7.metrics,w),(0,a.p)(p.G4.RECORD,[],void 0,n.K7.sessionReplay,w)},h[p.G4.PAUSE]=function(){(0,a.p)(f.xV,["API/pauseReplay/called"],void 0,n.K7.metrics,w),(0,a.p)(p.G4.PAUSE,[],void 0,n.K7.sessionReplay,w)},h.interaction=function(e){return(new T).get("object"==typeof e?e:{})};const S=T.prototype={createTracer:function(e,t){var r={},i=this,o="function"==typeof t;return(0,a.p)(f.xV,["API/createTracer/called"],void 0,n.K7.metrics,w),g||(0,a.p)(_+"tracer",[(0,m.t)(),e,r],i,n.K7.spa,w),function(){if(A.emit((o?"":"no-")+"fn-start",[(0,m.t)(),i,o],r),o)try{return t.apply(this,arguments)}catch(e){const t="string"==typeof e?new Error(e):e;throw A.emit("fn-err",[arguments,this,t],r),t}finally{A.emit("fn-end",[(0,m.t)()],r)}}}};function j(e,t,r,i){return function(){return(0,a.p)(f.xV,["API/"+t+"/called"],void 0,n.K7.metrics,w),i&&(0,a.p)(e+t,[(0,m.t)(),...arguments],r?null:this,i,w),r?void 0:this}}function k(){r.e(296).then(r.bind(r,8778)).then((({setAPI:t})=>{t(e),(0,c.Ze)(e,"api")})).catch((e=>{(0,l.R)(27,e),w.abort()}))}return["actionText","setName","setAttribute","save","ignore","onEnd","getContext","end","get"].forEach((e=>{S[e]=j(_,e,void 0,g?n.K7.softNav:n.K7.spa)})),h.setCurrentRouteName=g?j(_,"routeName",void 0,n.K7.softNav):j(E,"routeName",!0,n.K7.spa),h.noticeError=function(t,r){"string"==typeof t&&(t=new Error(t)),(0,a.p)(f.xV,["API/noticeError/called"],void 0,n.K7.metrics,w),(0,a.p)("err",[t,(0,m.t)(),!1,r,!!x[e]],void 0,n.K7.jserrors,w)},d.RI?(0,u.GG)((()=>k()),!0):k(),h}var N=r(9417),T=r(8122);const S={accountID:void 0,trustKey:void 0,agentID:void 0,licenseKey:void 0,applicationID:void 0,xpid:void 0},j={};var k=r(5284);const I=e=>{const t=e.startsWith("http");e+="/",r.p=t?e:"https://"+e};let O=!1;function P(e,t={},r,n){let{init:a,info:c,loader_config:u,runtime:l={},exposed:f=!0}=t;l.loaderType=r;const p=(0,g.pV)();c||(a=p.init,c=p.info,u=p.loader_config),(0,N.xN)(e.agentIdentifier,a||{}),function(e,t){if(!e)throw new Error("All loader-config objects require an agent identifier!");j[e]=(0,T.a)(t,S);const r=(0,g.nY)(e);r&&(r.loader_config=j[e])}(e.agentIdentifier,u||{}),c.jsAttributes??={},d.bv&&(c.jsAttributes.isWorker=!0),(0,i.x1)(e.agentIdentifier,c);const h=(0,N.D0)(e.agentIdentifier),v=[c.beacon,c.errorBeacon];O||(h.proxy.assets&&(I(h.proxy.assets),v.push(h.proxy.assets)),h.proxy.beacon&&v.push(h.proxy.beacon),E(),(0,g.US)("activatedFeatures",k.B),e.runSoftNavOverSpa&&=!0===h.soft_navigations.enabled&&h.feature_flags.includes("soft_nav")),l.denyList=[...h.ajax.deny_list||[],...h.ajax.block_internal?v:[]],l.ptid=e.agentIdentifier,(0,o.V)(e.agentIdentifier,l),e.ee=s.ee.get(e.agentIdentifier),void 0===e.api&&(e.api=_(e.agentIdentifier,n,e.runSoftNavOverSpa)),void 0===e.exposed&&(e.exposed=f),O=!0}},8374:(e,t,r)=>{r.nc=(()=>{try{return document?.currentScript?.nonce}catch(e){}return""})()},860:(e,t,r)=>{"use strict";r.d(t,{$J:()=>o,K7:()=>n,P3:()=>i});const n={ajax:"ajax",genericEvents:"generic_events",jserrors:"jserrors",logging:"logging",metrics:"metrics",pageAction:"page_action",pageViewEvent:"page_view_event",pageViewTiming:"page_view_timing",sessionReplay:"session_replay",sessionTrace:"session_trace",softNav:"soft_navigations",spa:"spa"},i={[n.pageViewEvent]:1,[n.pageViewTiming]:2,[n.metrics]:3,[n.jserrors]:4,[n.spa]:5,[n.ajax]:6,[n.sessionTrace]:7,[n.softNav]:8,[n.sessionReplay]:9,[n.logging]:10,[n.genericEvents]:11},o={[n.pageViewTiming]:"events",[n.ajax]:"events",[n.spa]:"events",[n.softNav]:"events",[n.metrics]:"jserrors",[n.jserrors]:"jserrors",[n.sessionTrace]:"browser/blobs",[n.sessionReplay]:"browser/blobs",[n.logging]:"browser/logs",[n.genericEvents]:"ins"}}},n={};function i(e){var t=n[e];if(void 0!==t)return t.exports;var o=n[e]={exports:{}};return r[e](o,o.exports,i),o.exports}i.m=r,i.d=(e,t)=>{for(var r in t)i.o(t,r)&&!i.o(e,r)&&Object.defineProperty(e,r,{enumerable:!0,get:t[r]})},i.f={},i.e=e=>Promise.all(Object.keys(i.f).reduce(((t,r)=>(i.f[r](e,t),t)),[])),i.u=e=>"nr-rum-1.274.0.min.js",i.o=(e,t)=>Object.prototype.hasOwnProperty.call(e,t),e={},t="NRBA-1.274.0.PROD:",i.l=(r,n,o,a)=>{if(e[r])e[r].push(n);else{var s,c;if(void 0!==o)for(var u=document.getElementsByTagName("script"),d=0;d<u.length;d++){var l=u[d];if(l.getAttribute("src")==r||l.getAttribute("data-webpack")==t+o){s=l;break}}if(!s){c=!0;var f={296:"sha512-gkYkZDAwQ9PwaDXs2YM+rNIdRej1Ac1mupWobRJ8eahQcXz6/sunGZCKklrzi5kWxhOGRZr2tn0rEKuLTXzfAA=="};(s=document.createElement("script")).charset="utf-8",s.timeout=120,i.nc&&s.setAttribute("nonce",i.nc),s.setAttribute("data-webpack",t+o),s.src=r,0!==s.src.indexOf(window.location.origin+"/")&&(s.crossOrigin="anonymous"),f[a]&&(s.integrity=f[a])}e[r]=[n];var g=(t,n)=>{s.onerror=s.onload=null,clearTimeout(p);var i=e[r];if(delete e[r],s.parentNode&&s.parentNode.removeChild(s),i&&i.forEach((e=>e(n))),t)return t(n)},p=setTimeout(g.bind(null,void 0,{type:"timeout",target:s}),12e4);s.onerror=g.bind(null,s.onerror),s.onload=g.bind(null,s.onload),c&&document.head.appendChild(s)}},i.r=e=>{"undefined"!=typeof Symbol&&Symbol.toStringTag&&Object.defineProperty(e,Symbol.toStringTag,{value:"Module"}),Object.defineProperty(e,"__esModule",{value:!0})},i.p="https://js-agent.newrelic.com/",(()=>{var e={840:0,374:0};i.f.j=(t,r)=>{var n=i.o(e,t)?e[t]:void 0;if(0!==n)if(n)r.push(n[2]);else{var o=new Promise(((r,i)=>n=e[t]=[r,i]));r.push(n[2]=o);var a=i.p+i.u(t),s=new Error;i.l(a,(r=>{if(i.o(e,t)&&(0!==(n=e[t])&&(e[t]=void 0),n)){var o=r&&("load"===r.type?"missing":r.type),a=r&&r.target&&r.target.src;s.message="Loading chunk "+t+" failed.\n("+o+": "+a+")",s.name="ChunkLoadError",s.type=o,s.request=a,n[1](s)}}),"chunk-"+t,t)}};var t=(t,r)=>{var n,o,[a,s,c]=r,u=0;if(a.some((t=>0!==e[t]))){for(n in s)i.o(s,n)&&(i.m[n]=s[n]);if(c)c(i)}for(t&&t(r);u<a.length;u++)o=a[u],i.o(e,o)&&e[o]&&e[o][0](),e[o]=0},r=self["webpackChunk:NRBA-1.274.0.PROD"]=self["webpackChunk:NRBA-1.274.0.PROD"]||[];r.forEach(t.bind(null,0)),r.push=t.bind(null,r.push.bind(r))})(),(()=>{"use strict";i(8374);var e=i(944),t=i(6344),r=i(9566);class n{agentIdentifier;constructor(e=(0,r.LA)(16)){this.agentIdentifier=e}#e(t,...r){if("function"==typeof this.api?.[t])return this.api[t](...r);(0,e.R)(35,t)}addPageAction(e,t){return this.#e("addPageAction",e,t)}setPageViewName(e,t){return this.#e("setPageViewName",e,t)}setCustomAttribute(e,t,r){return this.#e("setCustomAttribute",e,t,r)}noticeError(e,t){return this.#e("noticeError",e,t)}setUserId(e){return this.#e("setUserId",e)}setApplicationVersion(e){return this.#e("setApplicationVersion",e)}setErrorHandler(e){return this.#e("setErrorHandler",e)}addRelease(e,t){return this.#e("addRelease",e,t)}log(e,t){return this.#e("log",e,t)}}class o extends n{#e(t,...r){if("function"==typeof this.api?.[t])return this.api[t](...r);(0,e.R)(35,t)}start(){return this.#e("start")}finished(e){return this.#e("finished",e)}recordReplay(){return this.#e(t.G4.RECORD)}pauseReplay(){return this.#e(t.G4.PAUSE)}addToTrace(e){return this.#e("addToTrace",e)}setCurrentRouteName(e){return this.#e("setCurrentRouteName",e)}interaction(){return this.#e("interaction")}wrapLogger(e,t,r){return this.#e("wrapLogger",e,t,r)}}var a=i(860),s=i(9417);const c=Object.values(a.K7);function u(e){const t={};return c.forEach((r=>{t[r]=function(e,t){return!0===(0,s.gD)(t,"".concat(e,".enabled"))}(r,e)})),t}var d=i(7603);var l=i(1687),f=i(4234),g=i(5289),p=i(6154),h=i(384);const v=e=>p.RI&&!0===(0,s.gD)(e,"privacy.cookies_enabled");function m(e){return!!(0,h.dV)().o.MO&&v(e)&&!0===(0,s.gD)(e,"session_trace.enabled")}var b=i(6389);class y extends f.W{constructor(e,t,r=!0){super(e.agentIdentifier,t),this.auto=r,this.abortHandler=void 0,this.featAggregate=void 0,this.onAggregateImported=void 0,!1===e.init[this.featureName].autoStart&&(this.auto=!1),this.auto?(0,l.Ak)(e.agentIdentifier,t):this.ee.on("manual-start-all",(0,b.J)((()=>{(0,l.Ak)(e.agentIdentifier,this.featureName),this.auto=!0,this.importAggregator(e)})))}importAggregator(t,r={}){if(this.featAggregate||!this.auto)return;let n;this.onAggregateImported=new Promise((e=>{n=e}));const o=async()=>{let o;try{if(v(this.agentIdentifier)){const{setupAgentSession:e}=await i.e(296).then(i.bind(i,3861));o=e(t)}}catch(t){(0,e.R)(20,t),this.ee.emit("internal-error",[t]),this.featureName===a.K7.sessionReplay&&this.abortHandler?.()}try{if(t.sharedAggregator)await t.sharedAggregator;else{t.sharedAggregator=i.e(296).then(i.bind(i,9337));const{EventAggregator:e}=await t.sharedAggregator;t.sharedAggregator=new e}if(!this.#t(this.featureName,o))return(0,l.Ze)(this.agentIdentifier,this.featureName),void n(!1);const{lazyFeatureLoader:e}=await i.e(296).then(i.bind(i,6103)),{Aggregate:a}=await e(this.featureName,"aggregate");this.featAggregate=new a(t,r),n(!0)}catch(t){(0,e.R)(34,t),this.abortHandler?.(),(0,l.Ze)(this.agentIdentifier,this.featureName,!0),n(!1),this.ee&&this.ee.abort()}};p.RI?(0,g.GG)((()=>o()),!0):o()}#t(e,t){switch(e){case a.K7.sessionReplay:return m(this.agentIdentifier)&&!!t;case a.K7.sessionTrace:return!!t;default:return!0}}}var w=i(6630);class A extends y{static featureName=w.T;constructor(e,t=!0){super(e,w.T,t),this.importAggregator(e)}}var R=i(9908),E=i(2843),x=i(3878),_=i(782),N=i(1863);class T extends y{static featureName=_.T;constructor(e,t=!0){super(e,_.T,t),p.RI&&((0,E.u)((()=>(0,R.p)("docHidden",[(0,N.t)()],void 0,_.T,this.ee)),!0),(0,x.sp)("pagehide",(()=>(0,R.p)("winPagehide",[(0,N.t)()],void 0,_.T,this.ee))),this.importAggregator(e))}}var S=i(3969);class j extends y{static featureName=S.TZ;constructor(e,t=!0){super(e,S.TZ,t),this.importAggregator(e)}}new class extends o{constructor(t,r){super(r),p.gm?(this.features={},(0,h.bQ)(this.agentIdentifier,this),this.desiredFeatures=new Set(t.features||[]),this.desiredFeatures.add(A),this.runSoftNavOverSpa=[...this.desiredFeatures].some((e=>e.featureName===a.K7.softNav)),(0,d.j)(this,t,t.loaderType||"agent"),this.run()):(0,e.R)(21)}get config(){return{info:this.info,init:this.init,loader_config:this.loader_config,runtime:this.runtime}}run(){try{const t=u(this.agentIdentifier),r=[...this.desiredFeatures];r.sort(((e,t)=>a.P3[e.featureName]-a.P3[t.featureName])),r.forEach((r=>{if(!t[r.featureName]&&r.featureName!==a.K7.pageViewEvent)return;if(this.runSoftNavOverSpa&&r.featureName===a.K7.spa)return;if(!this.runSoftNavOverSpa&&r.featureName===a.K7.softNav)return;const n=function(e){switch(e){case a.K7.ajax:return[a.K7.jserrors];case a.K7.sessionTrace:return[a.K7.ajax,a.K7.pageViewEvent];case a.K7.sessionReplay:return[a.K7.sessionTrace];case a.K7.pageViewTiming:return[a.K7.pageViewEvent];default:return[]}}(r.featureName).filter((e=>!(e in this.features)));n.length>0&&(0,e.R)(36,{targetFeature:r.featureName,missingDependencies:n}),this.features[r.featureName]=new r(this)}))}catch(t){(0,e.R)(22,t);for(const e in this.features)this.features[e].abortHandler?.();const r=(0,h.Zm)();delete r.initializedAgents[this.agentIdentifier]?.api,delete r.initializedAgents[this.agentIdentifier]?.features,delete this.sharedAggregator;return r.ee.get(this.agentIdentifier).abort(),!1}}}({features:[A,T,j],loaderType:"lite"})})()})();</script> <link rel="canonical" href="https://investors.alnylam.com/financial-statements" /> <meta name="description" content="Find financial information for Alnylam Pharmaceuticals - including income statements, balance sheets, and cash flow statements." /> <meta name="keywords" content="alnylam pharmaceuticals, income statement, balance sheet, cash flow" /> <meta property="og:site_name" content="Investor Relations | Alnylam Pharmaceuticals, Inc." /> <meta property="og:type" content="website" /> <meta property="og:url" content="https://investors.alnylam.com/financial-statements" /> <meta property="og:title" content="Financial Statements | Alnylam Pharmaceuticals" /> <meta property="og:description" content="Find financial information including our income statements, balance sheets, and cash flow statements." /> <meta property="og:image" content="https://investors.alnylam.com/sites/default/files/Facebook/Facebook_1200x1200_Fundamentals.png" /> <meta name="twitter:card" content="summary" /> <meta name="twitter:description" content="Find financial information including our income statements, balance sheets, and cash flow statements." /> <meta name="twitter:title" content="Financial Statements | Alnylam Pharmaceuticals" /> <meta name="twitter:image" content="https://investors.alnylam.com/sites/default/files/twitter/Twitter_300x157_Fundamentals.png" /> <meta name="Generator" content="Drupal 9 (https://www.drupal.org)" /> <meta name="MobileOptimized" content="width" /> <meta name="HandheldFriendly" content="true" /> <meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="icon" href="/sites/default/files/fav_0.png" type="image/png" /> <script src="/sites/default/files/google_tag/google_tag/primary/google_tag.script.js?sm84ba" defer></script> <title>Financial Statements | Alnylam Pharmaceuticals, Inc.</title> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/align.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/fieldgroup.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/container-inline.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/clearfix.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/details.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/hidden.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/item-list.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/js.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/nowrap.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/position-container.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/progress.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/reset-appearance.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/resize.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/sticky-header.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/system-status-counter.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/system-status-report-counters.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/system-status-report-general-info.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/tablesort.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="/core/modules/system/css/components/tree-child.module.css?sm84ba" /> <link rel="stylesheet" media="all" href="https://use.fontawesome.com/releases/v5.10.0/css/all.css" /> <link rel="stylesheet" media="all" href="https://use.fontawesome.com/releases/v5.10.0/css/v4-shims.css" /> <link rel="stylesheet" media="all" href="https://cdn.jsdelivr.net/npm/bootstrap@3.4.1/dist/css/bootstrap.css" integrity="sha256-0XAFLBbK7DgQ8t7mRWU5BF2OMm9tjtfH945Z7TTeNIo=" crossorigin="anonymous" /> <link rel="stylesheet" media="all" href="https://cdn.jsdelivr.net/npm/@unicorn-fail/drupal-bootstrap-styles@0.0.2/dist/3.4.0/8.x-3.x/drupal-bootstrap.css" integrity="sha512-j4mdyNbQqqp+6Q/HtootpbGoc2ZX0C/ktbXnauPFEz7A457PB6le79qasOBVcrSrOBtGAm0aVU2SOKFzBl6RhA==" crossorigin="anonymous" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/font_face.css?sm84ba" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/to_maintain.css?sm84ba" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/style.css?sm84ba" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/main.css?sm84ba" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/mobile.css?sm84ba" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/superfish.css?sm84ba" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/navigation.css?sm84ba" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/ipad.css?sm84ba" /> <link rel="stylesheet" media="all" href="/themes/effvision/css/customtize.css?sm84ba" /> <link rel="stylesheet" media="all" href="/modules/custom/alnylam_search/css/alnylam_search.css?sm84ba" /> </head> <body class="node-27578 path-node page-node-type-page has-glyphicons"> <a href="#main-content" class="visually-hidden focusable skip-link"> Skip to main content </a> <noscript aria-hidden="true"><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WJ29M6J" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript> <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas> <section id="main-header"> <div class="region region-top-header"> <section id="block-header" class="block block-block-content block-block-contentb4d17b52-8aa6-4432-9b8e-8bc3dead9fab clearfix"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><header class="sticky"> <div id="whole-mobile-header" class="container-fluid"> <div class="mobile-block"> <div class="mobile-header-menu"> <div class="region region-mobile-menu"> <section id="block-mobilemainnavigation" class="block block-superfish block-superfishmobile-main-menu clearfix"> <div class="sf-accordion-toggle sf-style-none"> <a href="#" id="superfish-mobile-main-menu-toggle" class=""> <span>Mobile Main navigation</span> </a> </div> <ul id="superfish-mobile-main-menu-accordion" class="menu sf-menu sf-mobile-main-menu sf-style-none sf-accordion sf-accordion-with-buttons sf-hidden" style="display: block;"> <li id="mobile-main-menu-menu-link-content145d8319-203d-4f69-9e9d-f65fa2e47a85-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="our-company sf-depth-1 menuparent nolink sf-with-ul">Our Company</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content1a521d26-dfad-413c-8b97-cb55d153ab27-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam" class="our-company sf-depth-2" >About Alnylam</a> </li> <li id="mobile-main-menu-menu-link-content3ecf5446-204f-4d4d-82ab-46caa3a2d0ea-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/alnylam-leadership" class="our-company sf-depth-2" >Leadership</a> </li> <li id="mobile-main-menu-menu-link-content7d9ef835-8a46-4d4f-a857-dd70f686c3a7-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="our-company sf-depth-2" >Diversity, Equity & Inclusion</a> </li> <li id="mobile-main-menu-menu-link-content9063c2c0-d2ed-453c-a120-aef372aed146-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/patient-access-philosophy" class="our-company sf-depth-2" >Patient Access Philosophy</a> </li> <li id="mobile-main-menu-menu-link-content38c28e6b-b2e0-4683-9ea8-b5bba445a9a1-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/corporate-responsibility" class="our-company sf-depth-2" >Corporate Responsibility</a> </li> <li id="mobile-main-menu-menu-link-contentee2556f4-ca31-4621-8f1e-9efcd92847e1-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/transparency" class="our-company bullet-point sf-depth-2" >Transparency</a> </li> <li id="mobile-main-menu-menu-link-contentee2556f4-ca31-4621-8f1e-9efcd92847e1-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/grants-and-giving" class="our-company sf-depth-2" >Grants & Giving</a> </li> <li id="mobile-main-menu-menu-link-contentee2556f4-ca31-4621-8f1e-9efcd92847e1-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com//about-alnylam/grants-and-giving/advocacy-for-impact-grants" class="our-company bullet-point sf-depth-2" >Advocacy for Impact Grants</a> </li> <li id="mobile-main-menu-menu-link-contenta635d30a-0b18-42b3-8b46-bab6b3bd0f16-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies" class="our-company sf-depth-2" >Investigator Initiated Studies (IIS)</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-contentdb336fa7-b0e7-4022-87e2-84094cf624c4-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="our-science sf-depth-1 menuparent nolink sf-with-ul">Our Science</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-contentb7cb3399-2c54-40a5-9176-e8508a72790d-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/the-science-of-rnai" class="our-science sf-depth-2" >The Science of RNAi</a> </li> <li id="mobile-main-menu-menu-link-content2bb42bdf-0a8b-4bbe-8360-f23e436b781c-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/sirna-delivery-platforms" class="our-science sf-depth-2" >Delivery Platforms</a> </li> <li id="mobile-main-menu-menu-link-content864a206c-7443-43e2-a1fd-dc97104f13ee-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline" class="our-science sf-depth-2" >Therapeutic Areas</a> </li> <li id="mobile-main-menu-menu-link-content10eafc65-9679-480e-82cf-790a198bff23-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline" class="our-science bullet-point sf-depth-2" >Pipeline</a> </li> <li id="mobile-main-menu-menu-link-contentb3ebed05-afe1-4d4e-b2b9-2068791c8d6e-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials" class="our-science bullet-point sf-depth-2" >Clinical Trials</a> </li> <li id="mobile-main-menu-menu-link-content4a1a58d6-b693-42eb-b46e-d2ac0fb1a71c-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/alnylam-scientific-advisory-board" class="our-science sf-depth-2" >Scientific Advisory Board</a> </li> <li id="mobile-main-menu-menu-link-content92e775d9-ed7a-46e8-86c4-140b123ac958-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/intellectual-property" class="our-science sf-depth-2" >Intellectual Property</a> </li> <li id="mobile-main-menu-menu-link-content98520e22-8c64-4286-b38c-ab67cafad835-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/capella-rnai-innovation" class="our-science sf-depth-2" >Capella (Scientific Presentations)</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-content0e31c1a0-c1c2-4b4f-9c3e-5239ef378c62-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="our-products sf-depth-1 menuparent nolink sf-with-ul">Our Products</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content4e5215d6-d670-4423-9505-cadab42aed55-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-products" class="our-products sf-depth-2" >Product Listing</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-content367edda2-bdd9-483e-97fd-05c2a8eefdad-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="our-news sf-depth-1 menuparent nolink sf-with-ul">Our News</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-contentc7463cca-1961-4472-a53f-97592642e508-accordion" class="sf-depth-2 sf-no-children"> <a href="https://news.alnylam.com/" class="our-news sf-depth-2 sf-external" >Newsroom</a> </li> <li id="mobile-main-menu-menu-link-content44dc4173-805a-487f-af66-df33d15ac59e-accordion" class="sf-depth-2 sf-no-children"> <a href="/press-releases" class="our-news sf-depth-2 sf-external" >Press Releases</a> </li> <li id="mobile-main-menu-menu-link-content17141470-35b5-4b48-b5fc-1de4821ff87c-accordion" class="sf-depth-2 sf-no-children"> <a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/" class="our-news sf-depth-2 sf-external" >Capella (Scientific Presentations)</a> </li> <li id="mobile-main-menu-menu-link-content9e09cf1f-5dd1-4571-be9c-4411b7f06bb4-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/media-kit" class="our-news sf-depth-2" >Media Kit</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-content2fd397d7-c8cd-4255-977e-83d7914cc430-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="investors sf-depth-1 menuparent nolink sf-with-ul">Investors</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content6bee62a8-b6d6-4e27-a7fa-aa9a6e3656d5-accordion" class="sf-depth-2 sf-no-children"> <a href="/" class="sf-depth-2 sf-external" >For Investors</a> </li> <li id="mobile-main-menu-menu-link-content66876014-8534-4885-b003-e568f278d94a-accordion" class="sf-depth-2 sf-no-children"> <a href="/alny-stock-information" class="sf-depth-2 sf-external" >Stock Information</a> </li> <li id="mobile-main-menu-menu-link-content6ffc2aea-051a-497b-bffe-f7a1e1bfbcf6-accordion" class="sf-depth-2 sf-no-children"> <a href="/investor-toolkit" class="sf-depth-2 sf-external" >Investors Toolkit</a> </li> <li id="mobile-main-menu-menu-link-content011e25b7-dcaa-4ff3-abf5-940bf5675011-accordion" class="sf-depth-2 sf-no-children"> <a href="/events" class="sf-depth-2 sf-external" >Events & Presentations</a> </li> <li id="mobile-main-menu-menu-link-content944b0062-319c-4ba2-b99b-8d92a0b01ce8-accordion" class="sf-depth-2 sf-no-children"> <a href="/financial-information" class="sf-depth-2 sf-external" >Financial Information</a> </li> <li id="mobile-main-menu-menu-link-content898eeca9-13ee-4fa4-9256-9ecc67143686-accordion" class="sf-depth-2 sf-no-children"> <a href="/financial-information?sec=#sec_filings" class="sf-depth-2 sf-external" >SEC Filings</a> </li> <li id="mobile-main-menu-menu-link-contentbf34a89e-c1a7-4e2a-b74a-5db80bdeeb23-accordion" class="sf-depth-2 sf-no-children"> <a href="/corporate-governance" class="sf-depth-2 sf-external" >Corporate Governance</a> </li> <li id="mobile-main-menu-menu-link-content25975bd7-8f66-45d8-ac81-95efe8702691-accordion" class="sf-depth-2 sf-no-children"> <a href="/analyst-coverage" class="sf-depth-2 sf-external" >Analyst Coverage</a> </li> <li id="mobile-main-menu-menu-link-contente1a1245c-2631-41e6-81f8-6b63342f21f8-accordion" class="sf-depth-2 sf-no-children"> <a href="/financial-statements" class="sf-depth-2 sf-external" >Fundamentals</a> </li> <li id="mobile-main-menu-menu-link-content5e15851f-7957-41c0-be0d-728e1623c285-accordion" class="sf-depth-2 sf-no-children"> <a href="/ownership-profile" class="sf-depth-2 sf-external" >Ownership Profile</a> </li> <li id="mobile-main-menu-menu-link-content00f215d0-3d55-474b-9ded-f4c9402bfe70-accordion" class="sf-depth-2 sf-no-children"> <a href="/annual-meetings" class="sf-depth-2 sf-external" >Annual Meetings</a> </li> <li id="mobile-main-menu-menu-link-contentd3a6f148-04f6-4fa4-a4ea-c5c4fbf68583-accordion" class="sf-depth-2 sf-no-children"> <a href="/press-releases" class="sf-depth-2 sf-external" >Press Releases</a> </li> <li id="mobile-main-menu-menu-link-contente783ea22-3a21-4a31-ba98-319cd93575bd-accordion" class="sf-depth-2 sf-no-children"> <a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/" class="sf-depth-2 sf-external" >Capella (Scientific Presentations)</a> </li> <li id="mobile-main-menu-menu-link-content14ba81c4-1a33-474e-b5b6-442293872f36-accordion" class="sf-depth-2 sf-no-children"> <a href="/faq" class="sf-depth-2 sf-external" >FAQs</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-content906448e2-f167-4cb5-b599-a9c82258af65-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="medical-professionals sf-depth-1 menuparent nolink sf-with-ul">Medical Professionals</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content8ff0ac61-9365-4da7-b6d2-72faedf726c6-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources" class="sf-depth-2" >For Medical Professionals</a> </li> <li id="mobile-main-menu-menu-link-content75eab371-f4c0-4d8d-b708-4ce7f0684a83-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling" class="sf-depth-2" >Genetic Testing & Counseling</a> </li> <li id="mobile-main-menu-menu-link-content3c549964-6def-42ef-a42e-251434317abd-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/early-access-program" class="sf-depth-2" >Early Access Program</a> </li> <!--<li id="mobile-main-menu-menu-link-content3f22dfe0-5837-460b-b7a1-14d22ecbe83c-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/givosiran" class="our-science bullet-point sf-depth-2" >Givosiran Early Access</a> </li>--> <li id="mobile-main-menu-menu-link-contentb94d932b-35ba-4e21-86a1-408d4bacaa62-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/patisiran" class="our-science bullet-point sf-depth-2" >Patisiran Early Access</a> </li> <!--<li id="mobile-main-menu-menu-link-content088c72b9-e7d7-40e8-8465-27ab35b8547d-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/lumasiran" class="our-science bullet-point sf-depth-2" >Lumasiran Early Access</a> </li>--> <li id="mobile-main-menu-menu-link-content456745674567-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-publication-support" class="sf-depth-2" >Medical Publication Support</a> </li> <li id="mobile-main-menu-menu-link-contentbfb3ae05-e864-4ad6-aca2-1a7197a63860-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies" class="sf-depth-2" >Investigator Initiated Studies (IIS)</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-contented982836-a197-455a-9fda-574503a1f362-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="patients sf-depth-1 menuparent nolink sf-with-ul">Patients</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-contentc9ea7b10-6e86-4fdd-b927-6f58bc4468c6-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients" class="sf-depth-2" >For Patients</a> </li> <li id="mobile-main-menu-menu-link-content01045309-eed6-4435-b704-74147465f38e-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/amyloidosis" class="sf-depth-2" >Amyloidosis</a> </li> <li id="mobile-main-menu-menu-link-content94273325-8005-4ba9-b260-63cb7090050d-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/porphyria" class="sf-depth-2" >Acute Hepatic Porphyria</a> </li> <li id="mobile-main-menu-menu-link-contentfd77c281-d9fc-4d9e-a6d1-d0c2ff7342bc-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/primary-hyperoxaluria" class="sf-depth-2" >Primary Hyperoxaluria</a> </li> <li id="mobile-main-menu-menu-link-contentc4e83cc5-7a6c-4344-968a-fdb7521a7aa5-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/patient-services" class="sf-depth-2" >Patient Services</a> </li> <li id="mobile-main-menu-menu-link-content6da39404-d186-4dbc-a128-5259705d8f3e-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/genetic-testing-and-counseling-program" class="sf-depth-2" >Genetic Testing and Counseling</a> </li> <li id="mobile-main-menu-menu-link-content146dea73-fe73-41fb-84a9-2ec2ea763459-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/patient-advocacy" class="sf-depth-2" >Patient Advocacy</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-contentaa6af9e5-0676-4086-aa75-705491757e77-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="sf-depth-1 menuparent nolink sf-with-ul">Job Seekers</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-contentdc51b34c-4683-46b0-8ce1-d7bd3df9731c" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers" class="sf-depth-2">Careers</a></li> <li id="mobile-main-menu-menu-link-contentc0264ced-304c-4173-adad-d79f838e87c3" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/working-at-alnylam" class="sf-depth-2">Working at Alnylam</a></li> <li id="mobile-main-menu-menu-link-content79731843-7c0e-4027-857f-438feae903c3" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/who-we-are" class="sf-depth-2">Who We Are</a></li> <li id="mobile-main-menu-menu-link-content39047e9b-a716-471f-b7aa-fe9557564e21" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/opportunities" class="sf-depth-2">Career Opportunities</a></li> <li id="mobile-main-menu-menu-link-content9406752a-fbb8-4dc0-bb3e-eaad706d2e95" class="sf-depth-2 sf-no-children"> <a href="https://jobs.alnylam.com/careers" class="our-science bullet-point sf-depth-2 sf-depth-2 sf-external sf-depth-2 sf-external">Search Jobs</a></li> <li id="mobile-main-menu-menu-link-contentca342ef8-4bfc-4311-8e63-9196cddbba5f" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="sf-depth-2">Diversity, Equity & Inclusion</a></li> </ul> </li> <li id="mobile-main-menu-menu-link-content6ba287a9-37f6-45c6-924d-2985c62cf323-accordion" class="sf-depth-1 menuparent"> <a href="#" class="sf-accordion-button">Expand</a> <span class="quick-links sf-depth-1 menuparent nolink sf-with-ul">Quick Links</span> <ul style="float: none;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content0675b4ae-231d-4429-9d2b-d52fbf4a78dc-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials" class="sf-depth-2" >Clinical Trials</a> </li> <li id="mobile-main-menu-menu-link-content9fc493db-d879-4db6-9f01-0ea7a445ba15-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/corporate-responsibility" class="sf-depth-2" >Corporate Responsibility</a> </li> <li id="mobile-main-menu-menu-link-content2349be8e-3924-4327-95cd-599c456be6f5-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="sf-depth-2" >Diversity, Equity & Inclusion</a> </li> <li id="mobile-main-menu-menu-link-content369c2613-4f95-495f-b97d-7fe7704c1281-accordion" class="sf-depth-2 sf-no-children"> <a href="/press-releases" class="sf-depth-2" >Press Releases</a> </li> <li id="mobile-main-menu-menu-link-content9624843b-3ef8-4260-97fc-4719352453f5-accordion" class="sf-depth-2 sf-no-children"> <a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/" class="sf-depth-2" >Capella (Scientific Presentations)</a> </li> <li id="mobile-main-menu-menu-link-content54fe53ea-8cc4-4734-9e8b-b9e23b3774a0-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.rnaiscience.com/" target="_blank" class="sf-depth-2" >Medical Resources (RNAi Science)</a> </li> <li id="mobile-main-menu-menu-link-content54fe53ea-8cc4-4734-9e8b-b9e23b3774a0-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/contact-us" class="sf-depth-2" >Contact Us</a> </li> </ul> </li> <div class="mobile-sociallinks-block"> <li>Follow Us:</li> <li class="youtube"> <a href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw" target="_blank" title="youtube"> <i class="fab fa-youtube"> <span>youtube</span> </i> </a> </li> <li class="facebook"> <a href="https://facebook.com/alnylampharma" target="_blank" title="facebook"> <i class="fab fa-facebook"> <span>facebook</span> </i> </a> </li> <li class="twitter"> <a href="https://twitter.com/alnylam" target="_blank" title="X"> <i class="fab fa-twitter"> <span>X</span> </i> </a> </li> <li class="linkedin"> <a href="https://www.linkedin.com/company/alnylam-pharmaceuticals/" target="_blank" title="linkedin"> <i class="fab fa-linkedin-in"> <span>linkedin</span> </i> </a> </li> <li class="instagram"> <a href="https://www.instagram.com/alnylampharma/" target="_blank" title="instagram"> <i class="fab fa-instagram"> <span>instagram</span> </i> </a> </li> <li class="mail"> <a href="https://www.alnylam.com/signup-for-updates" target="_blank" title="Sign Up"> <i class="fa fa-envelope"> <span>Sign Up</span> </i> </a> </li> </div> </ul> <ul id="superfish-mobile-main-menu" class="menu sf-menu sf-mobile-main-menu sf-horizontal sf-style-none sf-js-enabled sf-shadow" style="display: none;"> <li id="mobile-main-menu-menu-link-content145d8319-203d-4f69-9e9d-f65fa2e47a85" class="sf-depth-1 menuparent"> <span class="our-company sf-depth-1 menuparent nolink sf-with-ul">Our Company <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content1a521d26-dfad-413c-8b97-cb55d153ab27" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam" class="our-company sf-depth-2" >About Alnylam</a> </li> <li id="mobile-main-menu-menu-link-content3ecf5446-204f-4d4d-82ab-46caa3a2d0ea" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/alnylam-leadership" class="our-company sf-depth-2" >Leadership</a> </li> <li id="mobile-main-menu-menu-link-content7d9ef835-8a46-4d4f-a857-dd70f686c3a7" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="our-company sf-depth-2" >Diversity, Equity & Inclusion</a> </li> <li id="mobile-main-menu-menu-link-content9063c2c0-d2ed-453c-a120-aef372aed146" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/patient-access-philosophy" class="our-company sf-depth-2" >Patient Access Philosophy</a> </li> <li id="mobile-main-menu-menu-link-content38c28e6b-b2e0-4683-9ea8-b5bba445a9a1" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/corporate-responsibility" class="our-company sf-depth-2" >Corporate Responsibility</a> </li> <li id="mobile-main-menu-menu-link-contentee2556f4-ca31-4621-8f1e-9efcd92847e1" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/transparency" class="our-company bullet-point sf-depth-2" >Transparency</a> </li> <li id="mobile-main-menu-menu-link-contentee2556f4-ca31-4621-8f1e-9efcd92847e1" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/grants-and-giving" class="our-company sf-depth-2" >Grants & Giving</a> </li> <li id="mobile-main-menu-menu-link-contentee2556f4-ca31-4621-8f1e-9efcd92847e1" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com//about-alnylam/grants-and-giving/advocacy-for-impact-grants" class="our-company bullet-point sf-depth-2" >Advocacy for Impact Grants</a> </li> <li id="mobile-main-menu-menu-link-contenta635d30a-0b18-42b3-8b46-bab6b3bd0f16" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies" class="our-company sf-depth-2" >Investigator Initiated Studies (IIS)</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-contentdb336fa7-b0e7-4022-87e2-84094cf624c4" class="sf-depth-1 menuparent"> <span class="our-science sf-depth-1 menuparent nolink sf-with-ul">Our Science <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-contentb7cb3399-2c54-40a5-9176-e8508a72790d" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/our-science/the-science-of-rnai" class="our-science sf-depth-2" >The Science of RNAi</a> </li> <li id="mobile-main-menu-menu-link-content2bb42bdf-0a8b-4bbe-8360-f23e436b781c" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/our-science/sirna-delivery-platforms" class="our-science sf-depth-2" >Delivery Platforms</a> </li> <li id="mobile-main-menu-menu-link-content864a206c-7443-43e2-a1fd-dc97104f13ee" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/alnylam-rnai-pipeline" class="our-science sf-depth-2" >Therapeutic Areas</a> </li> <li id="mobile-main-menu-menu-link-content10eafc65-9679-480e-82cf-790a198bff23" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/alnylam-rnai-pipeline" class="our-science bullet-point sf-depth-2" >Pipeline</a> </li> <li id="mobile-main-menu-menu-link-contentb3ebed05-afe1-4d4e-b2b9-2068791c8d6e" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials" class="our-science bullet-point sf-depth-2" >Clinical Trials</a> </li> <li id="mobile-main-menu-menu-link-content4a1a58d6-b693-42eb-b46e-d2ac0fb1a71c" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/our-science/alnylam-scientific-advisory-board" class="our-science sf-depth-2" >Scientific Advisory Board</a> </li> <li id="mobile-main-menu-menu-link-content92e775d9-ed7a-46e8-86c4-140b123ac958" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/our-science/intellectual-property" class="our-science sf-depth-2" >Intellectual Property</a> </li> <li id="mobile-main-menu-menu-link-content98520e22-8c64-4286-b38c-ab67cafad835" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/our-science/capella-rnai-innovation" class="our-science sf-depth-2" >Capella (Scientific Presentations)</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-content0e31c1a0-c1c2-4b4f-9c3e-5239ef378c62" class="sf-depth-1 menuparent"> <span class="our-products sf-depth-1 menuparent nolink sf-with-ul">Our Products <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content4e5215d6-d670-4423-9505-cadab42aed55" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/our-products" class="our-products sf-depth-2" >Product Listing</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-content367edda2-bdd9-483e-97fd-05c2a8eefdad" class="sf-depth-1 menuparent"> <span class="our-news sf-depth-1 menuparent nolink sf-with-ul">Our News <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-contentc7463cca-1961-4472-a53f-97592642e508" class="sf-depth-2 sf-no-children" > <a href="https://news.alnylam.com/" class="our-news sf-depth-2 sf-external" >Newsroom</a> </li> <li id="mobile-main-menu-menu-link-content44dc4173-805a-487f-af66-df33d15ac59e" class="sf-depth-2 sf-no-children" > <a href="/press-releases" class="our-news sf-depth-2 sf-external" >Press Releases</a> </li> <li id="mobile-main-menu-menu-link-content17141470-35b5-4b48-b5fc-1de4821ff87c" class="sf-depth-2 sf-no-children" > <a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/" class="our-news sf-depth-2 sf-external" >Capella (Scientific Presentations)</a> </li> <li id="mobile-main-menu-menu-link-content9e09cf1f-5dd1-4571-be9c-4411b7f06bb4" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/media-kit" class="our-news sf-depth-2" >Media Kit</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-content2fd397d7-c8cd-4255-977e-83d7914cc430" class="sf-depth-1 menuparent"> <span class="investors sf-depth-1 menuparent nolink sf-with-ul">Investors <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content6bee62a8-b6d6-4e27-a7fa-aa9a6e3656d5" class="sf-depth-2 sf-no-children" > <a href="/" class="sf-depth-2 sf-external" >For Investors</a> </li> <li id="mobile-main-menu-menu-link-content66876014-8534-4885-b003-e568f278d94a" class="sf-depth-2 sf-no-children" > <a href="/alny-stock-information" class="sf-depth-2 sf-external" >Stock Information</a> </li> <li id="mobile-main-menu-menu-link-content6ffc2aea-051a-497b-bffe-f7a1e1bfbcf6" class="sf-depth-2 sf-no-children" > <a href="/investor-toolkit" class="sf-depth-2 sf-external" >Investors Toolkit</a> </li> <li id="mobile-main-menu-menu-link-content011e25b7-dcaa-4ff3-abf5-940bf5675011" class="sf-depth-2 sf-no-children" > <a href="/events" class="sf-depth-2 sf-external" >Events & Presentations</a> </li> <li id="mobile-main-menu-menu-link-content944b0062-319c-4ba2-b99b-8d92a0b01ce8" class="sf-depth-2 sf-no-children" > <a href="/financial-information" class="sf-depth-2 sf-external" >Financial Information</a> </li> <li id="mobile-main-menu-menu-link-content898eeca9-13ee-4fa4-9256-9ecc67143686" class="sf-depth-2 sf-no-children" > <a href="/financial-information?sec=#sec_filings" class="sf-depth-2 sf-external" >SEC Filings</a> </li> <li id="mobile-main-menu-menu-link-contentbf34a89e-c1a7-4e2a-b74a-5db80bdeeb23" class="sf-depth-2 sf-no-children" > <a href="/corporate-governance" class="sf-depth-2 sf-external" >Corporate Governance</a> </li> <li id="mobile-main-menu-menu-link-content25975bd7-8f66-45d8-ac81-95efe8702691" class="sf-depth-2 sf-no-children" > <a href="/analyst-coverage" class="sf-depth-2 sf-external" >Analyst Coverage</a> </li> <li id="mobile-main-menu-menu-link-contente1a1245c-2631-41e6-81f8-6b63342f21f8" class="sf-depth-2 sf-no-children" > <a href="/financial-statements" class="sf-depth-2 sf-external" >Fundamentals</a> </li> <li id="mobile-main-menu-menu-link-content5e15851f-7957-41c0-be0d-728e1623c285" class="sf-depth-2 sf-no-children" > <a href="/ownership-profile" class="sf-depth-2 sf-external" >Ownership Profile</a> </li> <li id="mobile-main-menu-menu-link-content00f215d0-3d55-474b-9ded-f4c9402bfe70" class="sf-depth-2 sf-no-children" > <a href="/annual-meetings" class="sf-depth-2 sf-external" >Annual Meetings</a> </li> <li id="mobile-main-menu-menu-link-contentd3a6f148-04f6-4fa4-a4ea-c5c4fbf68583" class="sf-depth-2 sf-no-children" > <a href="/press-releases" class="sf-depth-2 sf-external" >Press Releases</a> </li> <li id="mobile-main-menu-menu-link-contente783ea22-3a21-4a31-ba98-319cd93575bd" class="sf-depth-2 sf-no-children" > <a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/" class="sf-depth-2 sf-external" >Capella (Scientific Presentations)</a> </li> <li id="mobile-main-menu-menu-link-content14ba81c4-1a33-474e-b5b6-442293872f36" class="sf-depth-2 sf-no-children" > <a href="/faq" class="sf-depth-2 sf-external" >FAQs</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-content906448e2-f167-4cb5-b599-a9c82258af65" class="sf-depth-1 menuparent"> <span class="medical-professionals sf-depth-1 menuparent nolink sf-with-ul">Medical Professionals <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content8ff0ac61-9365-4da7-b6d2-72faedf726c6" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/medical-professional-resources" class="sf-depth-2" >For Medical Professionals</a> </li> <li id="mobile-main-menu-menu-link-content75eab371-f4c0-4d8d-b708-4ce7f0684a83" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling" class="sf-depth-2" >Genetic Testing & Counseling</a> </li> <li id="mobile-main-menu-menu-link-content3c549964-6def-42ef-a42e-251434317abd" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/medical-professional-resources/early-access-program" class="sf-depth-2" >Early Access Program</a> </li> <!--<li id="mobile-main-menu-menu-link-content3f22dfe0-5837-460b-b7a1-14d22ecbe83c" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/givosiran" class="our-science bullet-point sf-depth-2" >Givosiran Early Access</a> </li>--> <li id="mobile-main-menu-menu-link-contentb94d932b-35ba-4e21-86a1-408d4bacaa62" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/patisiran" class="our-science bullet-point sf-depth-2" >Patisiran Early Access</a> </li> <!--<li id="mobile-main-menu-menu-link-content088c72b9-e7d7-40e8-8465-27ab35b8547d" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/lumasiran" class="our-science bullet-point sf-depth-2" >Lumasiran Early Access</a> </li>--> <li id="mobile-main-menu-menu-link-content43547634534-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-publication-support" class="sf-depth-2" >Medical Publication Support</a> </li> <li id="mobile-main-menu-menu-link-contentbfb3ae05-e864-4ad6-aca2-1a7197a63860" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies" class="sf-depth-2" >Investigator Initiated Studies (IIS)</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-contented982836-a197-455a-9fda-574503a1f362" class="sf-depth-1 menuparent"> <span class="patients sf-depth-1 menuparent nolink sf-with-ul">Patients <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-contentc9ea7b10-6e86-4fdd-b927-6f58bc4468c6" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/patients" class="sf-depth-2" >For Patients</a> </li> <li id="mobile-main-menu-menu-link-content01045309-eed6-4435-b704-74147465f38e" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/patients/amyloidosis" class="sf-depth-2" >Amyloidosis</a> </li> <li id="mobile-main-menu-menu-link-content94273325-8005-4ba9-b260-63cb7090050d" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/patients/porphyria" class="sf-depth-2" >Acute Hepatic Porphyria</a> </li> <li id="mobile-main-menu-menu-link-contentfd77c281-d9fc-4d9e-a6d1-d0c2ff7342bc" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/patients/primary-hyperoxaluria" class="sf-depth-2" >Primary Hyperoxaluria</a> </li> <li id="mobile-main-menu-menu-link-contentc4e83cc5-7a6c-4344-968a-fdb7521a7aa5" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/patients/patient-services" class="sf-depth-2" >Patient Services</a> </li> <li id="mobile-main-menu-menu-link-content6da39404-d186-4dbc-a128-5259705d8f3e" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/patients/genetic-testing-and-counseling-program" class="sf-depth-2" >Genetic Testing and Counseling</a> </li> <li id="mobile-main-menu-menu-link-content146dea73-fe73-41fb-84a9-2ec2ea763459" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/patients/patient-advocacy" class="sf-depth-2" >Patient Advocacy</a> </li> </ul> </li> <li id="mobile-main-menu-menu-link-contentaa6af9e5-0676-4086-aa75-705491757e77" class="sf-depth-1 menuparent"> <span class="sf-depth-1 menuparent nolink sf-with-ul">Job Seekers <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-contentdc51b34c-4683-46b0-8ce1-d7bd3df9731c" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers" class="sf-depth-2">Careers</a></li> <li id="mobile-main-menu-menu-link-contentc0264ced-304c-4173-adad-d79f838e87c3" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/working-at-alnylam" class="sf-depth-2">Working at Alnylam</a></li> <li id="mobile-main-menu-menu-link-content79731843-7c0e-4027-857f-438feae903c3" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/who-we-are" class="sf-depth-2">Who We Are</a></li> <li id="mobile-main-menu-menu-link-content39047e9b-a716-471f-b7aa-fe9557564e21" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/opportunities" class="sf-depth-2">Career Opportunities</a></li> <li id="mobile-main-menu-menu-link-content9406752a-fbb8-4dc0-bb3e-eaad706d2e95" class="sf-depth-2 sf-no-children"> <a href="https://jobs.alnylam.com/careers" class="our-science bullet-point sf-depth-2 sf-depth-2 sf-external sf-depth-2 sf-external">Search Jobs</a></li> <li id="mobile-main-menu-menu-link-contentca342ef8-4bfc-4311-8e63-9196cddbba5f" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="sf-depth-2">Diversity, Equity & Inclusion</a></li> </ul> </li> <li id="mobile-main-menu-menu-link-content6ba287a9-37f6-45c6-924d-2985c62cf323" class="sf-depth-1 menuparent"> <span class="quick-links sf-depth-1 menuparent nolink sf-with-ul">Quick Links <span class="sf-sub-indicator"> »</span> </span> <ul style="float: none; width: auto;" class="sf-hidden"> <li id="mobile-main-menu-menu-link-content0675b4ae-231d-4429-9d2b-d52fbf4a78dc" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials" class="sf-depth-2" >Clinical Trials</a> </li> <li id="mobile-main-menu-menu-link-content9fc493db-d879-4db6-9f01-0ea7a445ba15" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/corporate-responsibility" class="sf-depth-2" >Corporate Responsibility</a> </li> <li id="mobile-main-menu-menu-link-content2349be8e-3924-4327-95cd-599c456be6f5" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="sf-depth-2" >Diversity, Equity & Inclusion</a> </li> <li id="mobile-main-menu-menu-link-content369c2613-4f95-495f-b97d-7fe7704c1281" class="sf-depth-2 sf-no-children" > <a href="/press-releases" class="sf-depth-2" >Press Releases</a> </li> <li id="mobile-main-menu-menu-link-content9624843b-3ef8-4260-97fc-4719352453f5" class="sf-depth-2 sf-no-children" > <a href="" class="sf-depth-2" >Capella (Scientific Presentations)</a> </li> <li id="mobile-main-menu-menu-link-content54fe53ea-8cc4-4734-9e8b-b9e23b3774a0" class="sf-depth-2 sf-no-children" > <a href="https://www.rnaiscience.com/" target="_blank" class="sf-depth-2" >Medical Resources (RNAi Science)</a> </li> <li id="mobile-main-menu-menu-link-content54fe53ea-8cc4-4734-9e8b-b9e23b3774a0" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/contact-us" class="sf-depth-2" >Contact Us</a> </li> </ul> </li> <div class="mobile-sociallinks-block"> <li>Follow Us:</li> <li class="youtube"> <a href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw" target="_blank" title="youtube"> <i class="fab fa-youtube"> <span>youtube</span> </i> </a> </li> <li class="facebook"> <a href="https://facebook.com/alnylampharma" target="_blank" title="facebook"> <i class="fab fa-facebook"> <span>facebook</span> </i> </a> </li> <li class="twitter"> <a href="https://twitter.com/alnylam" target="_blank" title="X"> <i class="fab fa-twitter"> <span>X</span> </i> </a> </li> <li class="linkedin"> <a href="https://www.linkedin.com/company/alnylam-pharmaceuticals/" target="_blank" title="linkedin"> <i class="fab fa-linkedin-in"> <span>linkedin</span> </i> </a> </li> <li class="instagram"> <a href="https://www.instagram.com/alnylampharma/" target="_blank" title="instagram"> <i class="fab fa-instagram"> <span>instagram</span> </i> </a> </li> <li class="mail"> <a href="https://www.alnylam.com/signup-for-updates" target="_blank" title="Sign Up"> <i class="fa fa-envelope"> <span>Sign Up</span> </i> </a> </li> </div> </ul> </section> </div> </div> <div class="mobile-header-logo"> <div class="region region-mobile-logo"> <a class="logo navbar-btn pull-left" href="https://www.alnylam.com/" title="Home" rel="home"> <img src="/themes/effvision/images/mobile/mob-logo.svg" alt="Home"> </a> </div> </div> <div class="mobile-header-search"> <div class="region region-mobile-search"> <section id="block-headerrightsearch-2" class="block block-block-content block-block-content42903b0f-16f1-4041-a435-f95629feecc8 clearfix"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"> <div class="header-right-search block">search</div> </div> </section> <section class="views-exposed-form block block-views block-views-exposed-filter-blocksearch-content-page-1 clearfix" data-drupal-selector="views-exposed-form-search-content-page-1" id="block-exposedformsearch-contentpage-1"> <form action="/search-results" method="GET" id="views-exposed-form-search-content-page-1" accept-charset="UTF-8"> <div class="form--inline form-inline clearfix"> <div class="form-item js-form-item form-type-textfield js-form-type-textfield form-item-search-api-fulltext js-form-item-search-api-fulltext form-no-label form-group"> <input placeholder="Type something" data-drupal-selector="edit-search-api-fulltext" class="form-text form-control" type="text" id="edit-search-api-fulltext" name="keyword" value="" size="30" maxlength="128"> </div> <div class="form-item js-form-item form-type-select js-form-type-select form-item-sort-by js-form-item-sort-by form-group"> <label for="edit-sort-by" class="control-label">Sort by</label> <div class="select-wrapper"> <select data-drupal-selector="edit-sort-by" class="form-select form-control" id="edit-sort-by" name="sort_by"> <option value="sort_by" selected="selected">Sort By:</option> </select> </div> </div> <div class="form-item js-form-item form-type-select js-form-type-select form-item-sort-order js-form-item-sort-order form-group"> <label for="edit-sort-order" class="control-label">Order</label> <div class="select-wrapper"> <select data-drupal-selector="edit-sort-order" class="form-select form-control" id="edit-sort-order" name="sort_order"> <option value="ASC">Sort by: Most Recent</option> <option value="DESC" selected="selected">Sort by: Oldest</option> </select> </div> </div> <div data-drupal-selector="edit-actions" class="form-actions form-group js-form-wrapper form-wrapper" id="edit-actions"> <button data-drupal-selector="edit-submit-search-content" class="button js-form-submit form-submit btn-primary btn icon-before" type="submit" id="edit-submit-search-content" value="Search" name=""> <span class="icon glyphicon glyphicon-search" aria-hidden="true"></span> Search </button> </div> </div> </form> </section> <section id="block-language-2" class="block block-block-content block-block-content5a7dc698-6efe-4c02-a3cd-adb2377d4faf clearfix"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"> <div class="language block" id="language-switcher-icon">language <i class="fas fa-angle-down"></i> </div> </div> </section> <section id="block-languageswitcher-2" class="block block-block-content block-block-content4a663d92-67bc-4ad7-997c-8ad8f4f6a3aa clearfix"> <div class="field field--name-field-language-link field--type-entity-reference-revisions field--label-hidden field--items"> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--107 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Global</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/">English</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--108 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Austria</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-austria">Deutsch</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--110 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Belgium</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-belgium-dutch"> Nederlands</a> </div> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-belgium-french">Français</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--112 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Brazil </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com.br/">Português</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--114 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Canada </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.ca/fr">Français </a> </div> <div class="field--item"> <a href="https://www.alnylam.ca/">English</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--1513 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Czech Republic</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-czech-republic">Čeština</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--116 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Denmark </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-denmark">Dansk</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--118 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">France</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.fr/">Français</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--120 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Germany </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.de/">Deutsch</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--1514 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Ireland </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-ireland">English</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--122 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Italy</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.it/">Italiano</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--124 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Japan</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.jp/">日本語</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--109 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Luxembourg</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-luxembourg-french">Français</a> </div> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-luxembourg-german"> Deutsch</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--111 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Netherlands </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-netherlands">Nederlands</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--113 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Portugal</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-portugal">Português</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--115 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Spain </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-espana">Español</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--117 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Sweden</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-sverige">Svenska</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--119 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Switzerland</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-switzerland-french">Français</a> </div> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-switzerland-german">Deutsch</a> </div> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-switzerland-italian">Italiano</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--121 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Taiwan</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-taiwan">繁體中文</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--123 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">United Kingdom</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-uk">English</a> </div> </div> </span> </div> </div> </div> </div> </section> </div> </div> </div> </div> <div id="whole-header-top" class="container-fluid"> <div class="header-top-left col-sm-2"> <div class="region region-header-top-left"> <a class="logo navbar-btn pull-left" href="https://www.alnylam.com/" title="Home" rel="home"> <img src="/themes/effvision/images/logo/logo.svg" alt="Home" /> </a> </div> </div> <div class="header-top-middle col-sm-9"> <div class="region region-header-top-middle"> <section id="block-alnylam-topnavigation-3" class="block block-superfish block-superfishtop-navigation clearfix"> <ul id="superfish-top-navigation" class="menu sf-menu sf-top-navigation sf-horizontal sf-style-none"> <li id="top-navigation-menu-link-content64f38306-897f-4a7c-99eb-affe953acf01" class="sf-depth-1 menuparent"> <span class="is-active sf-depth-1 menuparent nolink">Investors</span> <ul> <li id="top-navigation-menu-link-content0099a821-634f-457b-bfed-bba6d6235d4f" class="sf-depth-2 sf-no-children"> <a href="/" class="sf-depth-2 sf-external">For Investors</a> </li> <li id="top-navigation-menu-link-contente1e1fcab-d6cb-4681-aec8-647dac1fe8f2" class="sf-depth-2 sf-no-children"> <a href="/alny-stock-information" class="sf-depth-2 sf-external">Stock Information</a> </li> <li id="top-navigation-menu-link-content37980c4c-fa7d-430a-9bb6-13addbb93796" class="sf-depth-2 sf-no-children"> <a href="/investor-toolkit" class="sf-depth-2 sf-external">Investors Toolkit</a> </li> <li id="top-navigation-menu-link-content8f5bcff2-d5da-45e2-b6df-8bb846a4edc4" class="sf-depth-2 sf-no-children"> <a href="/events" class="sf-depth-2 sf-external">Events & Presentations</a> </li> <li id="top-navigation-menu-link-content1cbbc9bd-ff86-41f1-b059-9004baaceb84" class="sf-depth-2 sf-no-children"> <a href="/financial-information" class="sf-depth-2 sf-external">Financial Information</a> </li> <li id="top-navigation-menu-link-content7a928654-3535-49aa-a4db-ba6e25e4c2a4" class="sf-depth-2 sf-no-children"> <a href="/financial-information?sec=#sec_filings" class="sf-depth-2 sf-external">SEC Filings</a> </li> <li id="top-navigation-menu-link-contentdc6a6762-e16f-4dbe-97a8-d241f845ee67" class="sf-depth-2 sf-no-children"> <a href="/corporate-governance" class="sf-depth-2 sf-external">Corporate Governance</a> </li> <li id="top-navigation-menu-link-contente6160938-8183-409f-a295-bf7b1e63e2a2" class="sf-depth-2 sf-no-children"> <a href="/analyst-coverage" class="sf-depth-2 sf-external">Analyst Coverage</a> </li> <li id="top-navigation-menu-link-contentedddf916-b737-47ab-aa6a-71253e61bc28" class="sf-depth-2 sf-no-children"> <a href="/financial-statements" class="sf-depth-2 sf-external">Fundamentals</a> </li> <li id="top-navigation-menu-link-content23cfb6f5-0d25-4522-a3fa-9d440596dfb3" class="sf-depth-2 sf-no-children"> <a href="/ownership-profile" class="sf-depth-2 sf-external">Ownership Profile</a> </li> <li id="top-navigation-menu-link-content4f9e088d-affc-4b7f-b98a-6c1f7ddf1592" class="sf-depth-2 sf-no-children"> <a href="/annual-meetings" class="sf-depth-2 sf-external">Annual Meetings</a> </li> <li id="top-navigation-menu-link-content93231329-f098-4532-a066-a1cf9788e312" class="sf-depth-2 sf-no-children"> <a href="/press-releases" class="sf-depth-2 sf-external">Press Releases</a> </li> <li id="top-navigation-menu-link-contentffd6b8ff-a8cc-4063-8dac-12013701ae47" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/capella-rnai-innovation/" class="sf-depth-2">Capella (Scientific Presentations)</a> </li> <li id="top-navigation-menu-link-content8de59c6c-bc28-4b23-8998-1925785f4b3b" class="sf-depth-2 sf-no-children"> <a href="/faq" class="sf-depth-2 sf-external">FAQs</a> </li> </ul> </li> <li id="top-navigation-menu-link-contentb36c196f-2f8e-4310-bc93-e5d878980127" class="sf-depth-1 menuparent"> <span class="is-active sf-depth-1 menuparent nolink">Medical Professionals</span> <ul> <li id="top-navigation-menu-link-content1c655bb6-b7e4-4589-be94-485f1cf130ba" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources" class="sf-depth-2">For Medical Professionals</a> </li> <li id="top-navigation-menu-link-content3000df5e-a317-48c2-8d12-9d35ff18ab84" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/genetic-testing-counseling" class="sf-depth-2">Genetic Testing & Counseling</a> </li> <li id="top-navigation-menu-link-contentc1f9e31b-6ba0-42a6-a7cc-bf017093d4fc" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/early-access-program" class="sf-depth-2">Early Access Program</a> </li> <!--<li id="top-navigation-menu-link-content7c6422db-b372-491d-8ce1-b9970ca351f0" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/givosiran" class="our-science bullet-point sf-depth-2">Givosiran Early Access</a> </li>--> <li id="top-navigation-menu-link-content0fb71b04-3380-43e5-bfe2-85fa58e84f69" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/patisiran" class="our-science bullet-point sf-depth-2">Patisiran Early Access</a> </li> <!--<li id="top-navigation-menu-link-content112671e2-704f-4dca-aa4c-613bee5a9a97" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-professional-resources/early-access-program/lumasiran" class="our-science bullet-point sf-depth-2">Lumasiran Early Access</a> </li>--> <li id="mobile-main-menu-menu-link-content3582358356-accordion" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/medical-publication-support" class="sf-depth-2" >Medical Publication Support</a> </li> <li id="top-navigation-menu-link-content35f0355d-0b74-4ff4-9312-750a27599d50" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies" class="sf-depth-2">Investigator Initiated Studies (IIS)</a> </li> </ul> </li> <li id="top-navigation-menu-link-content2c648995-20d4-4a54-8514-e596548347a3" class="sf-depth-1 menuparent"> <span class="is-active sf-depth-1 menuparent nolink">Patients</span> <ul> <li id="top-navigation-menu-link-content47262aab-cea7-4f48-bda3-892eb77e1fe5" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients" class="sf-depth-2">For Patients</a> </li> <li id="top-navigation-menu-link-content2aec25a1-fffc-47c4-afc6-9ecffea4a957" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/amyloidosis" class="sf-depth-2">Amyloidosis</a> </li> <li id="top-navigation-menu-link-content4f367b2f-c763-48c7-8b76-f0dc429c4207" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/porphyria" class="sf-depth-2">Acute Hepatic Porphyria</a> </li> <li id="top-navigation-menu-link-contentd793d1c5-e0d2-4f08-b118-fe5c25138c4a" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/primary-hyperoxaluria" class="sf-depth-2">Primary Hyperoxaluria</a> </li> <li id="top-navigation-menu-link-content69a9bc19-c8bd-441b-a9bc-201e56561aa6" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/patient-services" class="sf-depth-2">Patient Services</a> </li> <li id="top-navigation-menu-link-content0c9b008f-5b6c-4969-a855-569e25e69256" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/genetic-testing-and-counseling-program" class="sf-depth-2">Genetic Testing and Counseling</a> </li> <li id="top-navigation-menu-link-content36301e76-cc52-42f0-840a-fb6aa930051f" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/patients/patient-advocacy" class="sf-depth-2">Patient Advocacy</a> </li> </ul> </li> <li id="top-navigation-menu-link-content96409c7b-3b98-4591-aa4c-60c096b1757e" class="sf-depth-1 menuparent"> <span class="is-active sf-depth-1 menuparent nolink">Job Seekers</span> <ul> <li id="top-navigation-menu-link-contentb8a5d157-460c-4f44-8d99-d624cd918a2f" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers" class="sf-depth-2">Careers</a></li> <li id="top-navigation-menu-link-content9ce32415-4565-4d11-be6a-97b54089cb96" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/working-at-alnylam" class="sf-depth-2">Working at Alnylam</a></li> <li id="top-navigation-menu-link-contentc129b114-fc84-4b88-9b2c-80d8cd39201b" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/who-we-are" class="sf-depth-2">Who We Are</a></li> <li id="top-navigation-menu-link-contentaa194a9b-4646-4c04-bcd2-3cd775454f27" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/careers/opportunities" class="sf-depth-2">Career Opportunities</a></li> <li id="top-navigation-menu-link-contentcfa06c04-2fae-4d7a-9b56-d5b4d5390fe9" class="sf-depth-2 sf-no-children"> <a href="https://jobs.alnylam.com/careers" class="our-science bullet-point sf-depth-2 sf-depth-2 sf-external">Search Jobs</a></li> <li id="top-navigation-menu-link-content904aff3e-6234-4b0c-a23e-3a6a8b5b2674" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="sf-depth-2">Diversity, Equity & Inclusion </a></li> </ul> </li> <li id="top-navigation-menu-link-content0980788b-164c-4cd5-8344-f8ac256dab54" class="sf-depth-1 menuparent"> <span class="is-active sf-depth-1 menuparent nolink">Quick Links</span> <ul> <li id="top-navigation-menu-link-contente5b10497-a6bb-41c8-9c32-226abec4f73c" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials" class="sf-depth-2">Clinical Trials</a> </li> <li id="top-navigation-menu-link-content5586e07f-c18e-45aa-bf7a-6b1de2786d02" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/corporate-responsibility" class="sf-depth-2">Corporate Responsibility</a> </li> <li id="top-navigation-menu-link-content803e4ad3-61c9-42e0-97d1-d1a9bbce0b77" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="sf-depth-2">Diversity, Equity & Inclusion</a> </li> <li id="top-navigation-menu-link-content0226dfd4-4752-4faa-bf8c-6b325170cdb9" class="sf-depth-2 sf-no-children"> <a href="/press-releases" class="sf-depth-2 sf-external">Press Releases</a> </li> <li id="top-navigation-menu-link-content2e003df3-d61a-4c7e-8238-359dd2fe78a1" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/capella-rnai-innovation/" class="sf-depth-2">Capella (Scientific Presentations)</a> </li> <li id="top-navigation-menu-link-contenteeee7deb-d1d5-4aad-8ccd-e8931b990153" class="sf-depth-2 sf-no-children"> <a href="https://www.rnaiscience.com/" target="_blank" class="sf-depth-2" >Medical Resources (RNAi Science)</a> </li> <li id="top-navigation-menu-link-contenteeee7deb-d1d5-4aad-8ccd-e8931b990153" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/contact-us" class="sf-depth-2">Contact Us</a> </li> </ul> </li> <li id="top-navigation-menu-link-contentb323995c-f7d7-4b92-97c8-2b7f45bd1238" class="sf-depth-1 menuparent"> <span class="is-active sf-depth-1 menuparent nolink">Follow Us</span> <ul> <li id="top-navigation-menu-link-content0fd2a3b1-6274-4b0f-a0ea-8411d910ae71" class="sf-depth-2 sf-no-children"> <a href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw" class="youtube sf-depth-2 sf-external" target="_blank">Youtube</a> </li> <li id="top-navigation-menu-link-content0fd2a3b1-6274-4b0f-a0ea-8411d910ae71" class="sf-depth-2 sf-no-children"> <a href="https://facebook.com/alnylampharma" class="facebook sf-depth-2 sf-external" target="_blank">Facebook</a> </li> <li id="top-navigation-menu-link-contentbfa3443d-bb70-4c37-92ae-5c17ff981c83" class="sf-depth-2 sf-no-children"> <a href="https://twitter.com/alnylam" class="twitter sf-depth-2 sf-external" target="_blank">X</a> </li> <li id="top-navigation-menu-link-contentd6d243a3-6c5e-43f5-80d2-aabc43bbe67d" class="sf-depth-2 sf-no-children"> <a href="https://www.linkedin.com/company/alnylam-pharmaceuticals/" class="linkedin sf-depth-2 sf-external" target="_blank">LinkedIn</a> </li> <li id="top-navigation-menu-link-contentc4f4f8f8-c7b8-4d4e-a24c-0ba013135e39" class="sf-depth-2 sf-no-children"> <a href="https://www.instagram.com/alnylampharma/" class="instagram sf-depth-2 sf-external" target="_blank">Instagram</a> </li> <li id="top-navigation-menu-link-content75df3d3f-dce4-4177-b1c5-c55a5693b7ef" class="sf-depth-2 sf-no-children" > <a href="https://www.alnylam.com/signup-for-updates" class="mail sf-depth-2" target="_blank" >Sign Up</a> </li> </ul> </li> </ul> </section> </div> </div> <div class="header-top-right col-sm-1"> <div class="region region-header-top-right"> <section id="block-language" class="block block-block-content block-block-content5a7dc698-6efe-4c02-a3cd-adb2377d4faf clearfix"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"> <div id="language-switcher-icon" class="language block">language</div> </div> </section> </div> </div> </div> <div id="whole-header-bottom" class="container-fluid"> <div class="header-bottom-left col-sm-6"> <div class="region region-header-bottom-left"> <section id="block-alnylam-mainnavigation-2" class="block block-superfish block-superfishmain clearfix"> <ul id="superfish-main" class="menu sf-menu sf-main sf-horizontal sf-style-none"> <li id="main-menu-link-content16444554-bc00-4866-8d50-bcd4c1d40137" class="sf-depth-1 menuparent"> <span class="our-company-main is-active sf-depth-1 menuparent nolink">Our Company</span> <ul> <li id="main-menu-link-content71bb768d-2c89-4a16-a30f-c791eed5b4f7" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam" class="our-company sf-depth-2">About Alnylam</a> </li> <li id="main-menu-link-content70351e72-c6c5-43d4-b345-3bb49df5e786" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/alnylam-leadership" class="our-company sf-depth-2">Leadership</a> </li> <li id="main-menu-link-content8c50a23c-78e4-4889-9fe5-554635aef1ec" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/diversity-inclusion" class="our-company sf-depth-2">Diversity, Equity & Inclusion</a> </li> <li id="main-menu-link-contentcbeef0d8-528d-4af9-8348-83c33d5265d2" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/patient-access-philosophy" class="our-company sf-depth-2">Patient Access Philosophy</a> </li> <li id="main-menu-link-content86dc6ab6-a8ce-48ce-afe2-2c654951f4b7" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/corporate-responsibility" class="our-company sf-depth-2">Corporate Responsibility</a> </li> <li id="main-menu-link-contentafddbff1-65c3-4f96-9518-ee682c1e7435" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/transparency" class="our-company bullet-point sf-depth-2" >Transparency</a> </li> <li id="main-menu-link-contentafddbff1-65c3-4f96-9518-ee682c1e7435" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/grants-and-giving" class="our-company sf-depth-2">Grants & Giving</a> </li> <li id="main-menu-link-contentafddbff1-65c3-4f96-9518-ee682c1e7435" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com//about-alnylam/grants-and-giving/advocacy-for-impact-grants" class="our-company bullet-point sf-depth-2" >Advocacy for Impact Grants</a> </li> <li id="main-menu-link-content9680d412-096f-4480-9a9b-7c583a525a14" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/about-alnylam/investigator-initiated-studies" class="our-company sf-depth-2">Investigator Initiated Studies (IIS)</a> </li> </ul> </li> <li id="main-menu-link-contentab68e41a-a846-4e8e-aaf6-8367257469d5" class="sf-depth-1 menuparent"> <span class="our-science-main is-active sf-depth-1 menuparent nolink">Our Science</span> <ul> <li id="main-menu-link-content513c7576-4fed-4679-949e-4acbd2e8f63b" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/the-science-of-rnai" class="our-science sf-depth-2">The Science of RNAi</a> </li> <li id="main-menu-link-content3d097c54-868e-42b5-b066-30c47f1daff3" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/sirna-delivery-platforms" class="our-science sf-depth-2">Delivery Platforms</a> </li> <li id="main-menu-link-content9f7cf51f-2070-43b5-b60e-471c6e7d1bf2" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline" class="our-science sf-depth-2">Therapeutic Areas</a> </li> <li id="main-menu-link-content5de709d9-decf-49cc-a7bc-775915ced565" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline" class="our-science bullet-point sf-depth-2">Pipeline</a> </li> <li id="main-menu-link-content2dab5c64-c280-422a-bdf3-fa6e297e0493" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials" class="our-science bullet-point sf-depth-2">Clinical Trials</a> </li> <li id="main-menu-link-content4e516816-8cc6-4a5f-b7d0-8a15dbdffa2c" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/alnylam-scientific-advisory-board" class="our-science sf-depth-2">Scientific Advisory Board</a> </li> <li id="main-menu-link-contenteb5a676d-9e52-40d3-89e9-6e8f1fe245b8" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/intellectual-property" class="our-science sf-depth-2">Intellectual Property</a> </li> <li id="main-menu-link-contente7c1b927-7fb5-4fd0-82c2-05217ec61417" class="sf-depth-2 sf-no-children"> <a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/" class="our-science sf-depth-2 sf-external">Capella (Scientific Presentations)</a> </li> </ul> </li> <li id="main-menu-link-contente7c3c9c0-d010-45f3-a113-9b8a701f2c53" class="sf-depth-1 menuparent"> <span class="our-products-main is-active sf-depth-1 menuparent nolink">Our Products</span> <ul> <li id="main-menu-link-content8cee579b-4350-4f80-831e-895e28ab37e4" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-products" class="our-products sf-depth-2">Product Listing</a> </li> </ul> </li> <li id="main-menu-link-contentf1db7367-b7a4-4665-ba0e-52b56bcbe059" class="sf-depth-1 menuparent"> <span class="our-news-main is-active sf-depth-1 menuparent nolink">Our News</span> <ul> <li id="main-menu-link-content25f354e5-7a66-4058-b58f-ccd90894e67a" class="sf-depth-2 sf-no-children"> <a href="https://news.alnylam.com" class="our-news sf-depth-2 sf-external">Newsroom</a> </li> <li id="main-menu-link-content0ab21197-6fc8-4681-8e4e-4c00ccf93d76" class="sf-depth-2 sf-no-children"> <a href="/press-releases" class="our-news sf-depth-2 sf-external">Press Releases</a> </li> <li id="main-menu-link-content7f534fee-0f07-49f3-9d3a-104a50b6adad" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/our-science/capella-rnai-innovation/" class="our-news sf-depth-2">Capella (Scientific Presentations)</a> </li> <li id="main-menu-link-content05a96e94-d35a-440e-a308-46cc42a3dd0a" class="sf-depth-2 sf-no-children"> <a href="https://www.alnylam.com/media-kit" class="our-news sf-depth-2">Media Kit</a> </li> </ul> </li> </ul> </section> </div> </div> <div class="header-bottom-right col-sm-6"> <div class="region region-header-bottom-right"> <section id="block-basicsearchblock" class="block block-alnylam-search block-basic-search-block clearfix"> <div class="alnylam__basic-search-block"> <form action="/search-results" method="GET"> <div id="search-input" class="input-group hide"> <input type="text" name="keyword" placeholder="Type something"> <button type="submit">search</button> </div> <button type="button" id="search-open-btn"> <img src="themes/effvision/images/search-icon.png"> </button> <button type="button" id="search-close-btn" class="hide"> <img src="modules/custom/alnylam_search/images/search-close-icon.png"> </button> </form> </div> </section> <section class="views-exposed-form block block-views block-views-exposed-filter-blocksearch-content-page-1 clearfix" data-drupal-selector="views-exposed-form-search-content-page-1" id="block-exposedformsearch-contentpage-1-2"> <form action="/search-results" method="GET" id="views-exposed-form-search-content-page-1" accept-charset="UTF-8"> <div class="form--inline form-inline clearfix"> <div class="form-item js-form-item form-type-textfield js-form-type-textfield form-item-search-api-fulltext js-form-item-search-api-fulltext form-no-label form-group"> <input placeholder="Type something" data-drupal-selector="edit-search-api-fulltext" class="form-text form-control" type="text" id="edit-search-api-fulltext--2" name="keyword" value="" size="30" maxlength="128" /> </div> <div class="form-item js-form-item form-type-select js-form-type-select form-item-sort-by js-form-item-sort-by form-group"> <label for="edit-sort-by--2" class="control-label">Sort by</label> <div class="select-wrapper"> <select data-drupal-selector="edit-sort-by" class="form-select form-control" id="edit-sort-by--2" name="sort_by"> <option value="sort_by" selected="selected">Sort By:</option> </select> </div> </div> <div class="form-item js-form-item form-type-select js-form-type-select form-item-sort-order js-form-item-sort-order form-group"> <label for="edit-sort-order--2" class="control-label">Order</label> <div class="select-wrapper"> <select data-drupal-selector="edit-sort-order" class="form-select form-control" id="edit-sort-order--2" name="sort_order"> <option value="ASC">Sort by: Most Recent</option> <option value="DESC" selected="selected">Sort by: Oldest</option> </select> </div> </div> <div data-drupal-selector="edit-actions" class="form-actions form-group js-form-wrapper form-wrapper" id="edit-actions--2"> <button data-drupal-selector="edit-submit-search-content-2" class="button js-form-submit form-submit btn-primary btn icon-before" type="submit" id="edit-submit-search-content--2" value="Search" name=""> <span class="icon glyphicon glyphicon-search" aria-hidden="true"></span> Search </button> </div> </div> </form> </section> <section id="block-languageswitcher" class="block block-block-content block-block-content4a663d92-67bc-4ad7-997c-8ad8f4f6a3aa clearfix"> <div class="field field--name-field-language-link field--type-entity-reference-revisions field--label-hidden field--items"> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--107 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Global</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com">English</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--108 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Austria</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-austria">Deutsch</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--124 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Japan</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.jp/">日本語</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--110 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Belgium</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-belgium-dutch"> Nederlands</a> </div> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-belgium-french">Français</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--109 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Luxembourg</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-luxembourg-french">Français</a> </div> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-luxembourg-german"> Deutsch</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--112 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Brazil </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com.br/">Português</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--111 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Netherlands </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-netherlands">Nederlands</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--114 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Canada </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.ca/fr">Français </a> </div> <div class="field--item"> <a href="https://www.alnylam.ca/">English</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--113 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Portugal</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-portugal">Português</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--1513 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Czech Republic</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-czech-republic">Čeština</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--115 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Spain </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-espana">Español</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--116 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Denmark </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-denmark">Dansk</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--117 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Sweden</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-sverige">Svenska</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--118 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">France</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.fr/">Français</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--119 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Switzerland</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-switzerland-french">Français</a> </div> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-switzerland-german">Deutsch</a> </div> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-switzerland-italian">Italiano</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--120 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Germany </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.de/">Deutsch</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--121 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Taiwan</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-taiwan">繁體中文</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--1514 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Ireland </div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-ireland">English</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--123 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">United Kingdom</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.com/alnylam-uk">English</a> </div> </div> </span> </div> </div> </div> <div class="field--item"> <div class="paragraph paragraph--type--language-links paragraph-id--122 paragraph--view-mode--default"> <div class="language-switcher-main"> <span class="label-text"> <div class="field field--name-field-label field--type-string field--label-hidden field--item">Italy</div> </span> <span class="link-text"> <div class="field field--name-field-link1 field--type-link field--label-hidden field--items"> <div class="field--item"> <a href="https://www.alnylam.it/">Italiano</a> </div> </div> </span> </div> </div> </div> </div> </section> </div> </div> </div> </header></div> </section> <section id="block-scrollup" class="block block-block-content block-block-content8948513e-6567-48eb-b6bb-b5cd5ae812ce clearfix"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><a id="back_to_top" href="#" class="off"> <span class="fa-stack"> <i class="fa fa-arrow-up" style=""></i> </span> </a></div> </section> </div> </section> <!-- --> <div role="main" class="main-container js-quickedit-main-content"> <!-- <div class="row"> --> <div> <!-- <section class="col-sm-12"> --> <section> <a id="main-content"></a> <section id="" class="section clearfix hero-section mob-hide"> <div> <img src="/sites/default/files/2019-10/financial-information-hero.png" width="1280" height="184" alt="" typeof="foaf:Image" class="img-responsive"> </div> </section> <section id="" class="section clearfix hero-section-mobile"> <div> <img src="/sites/default/files/2019-10/financial-info-hero-mobile.png" alt="" typeof="foaf:Image" class="img-responsive" width="375" height="184"> </div> </section> <!-- Operations toolbar --> <section class="section clearfix container"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><div class="op-toolbar"> <div class="icon email"><a href="http://investors.alnylam.com/email-alerts"><img alt="file" class="img-responsive" data-entity-type="file" data-entity-uuid="efc213d0-b2fb-4429-bbae-edd71227d1bc" src="/sites/default/files/inline-images/group-6_0.png" width="16" height="16" loading="lazy" /></a></div> <!-- <div class="icon rss"><a href=""><img alt="Wifi" class="img-responsive" data-entity-type="file" data-entity-uuid="272424e9-52f8-434e-97ff-3f37129af6c7" src="/sites/default/files/inline-images/group-12_3.png" /></a></div>--> <div class="icon download"><a href="http://investors.alnylam.com/download-library"><img alt="download" class="img-responsive" data-entity-type="file" data-entity-uuid="92ad5440-5f91-4572-839c-af9ccd8bcb7b" src="/sites/default/files/inline-images/group-3_0.png" width="16" height="16" loading="lazy" /></a></div> <div class="icon print"><a href="#" onclick="window.print()"><img alt="print" class="img-responsive" data-entity-type="file" data-entity-uuid="3031929b-3dd3-47e5-85c6-515d403fbb6f" src="/sites/default/files/inline-images/group-8_4.png" width="16" height="16" loading="lazy" /></a></div> </div> </div> </section> <!-- page title --> <section class="section clearfix container mb-35"> <section class="section clearfix container-970"> <div class="toolkit-header"> <p class="mobile-eyebrow"><span class="our-secondary-dark">Fundamentals</span></p> <h2 class="section-header ">Fundamentals</h2> </div> </section> </section> <!-- Fundamentals table --> <section class="section clearfix container-970 mb-65"> <div class="ul-con"> <img class="fund-arrow" src="/sites/default/files/2019-10/right.png" alt="arrow" style="display:none"> <img class="fund-arrow-1" src="/sites/default/files/2019-10/left.svg" alt="arrow" style="display:none"> <ul class="nav nav-tabs"> <li><a data-toggle="tab" href="#income-statement">INCOME STATEMENT</a></li> <li><a data-toggle="tab" href="#balance-sheet">BALANCE SHEET</a></li> <li><a data-toggle="tab" href="#cash-flow">CASH FLOW</a></li> </ul> </div> <div class="divader "></div> <form action="/financial-statements" method="get"> <div class="fun-select"> <div id="timeframeic"> <p>Timeframe:</p> <div class="custom-select"> <select name="timeframe" id="timeframe"> <option value="annual">Annual</option> <option value="annual">Annual</option> <option value="quarterly">Quarterly</option> </select> </div> </div> <div id= "periodic"> <p>Period:</p> <div class="custom-select"> <select name="period" id="period"> <option value="current-financials">Current Financials</option> <option value="current-financials">Current Financials</option> <option value="compare">Compare</option> </select> </div> </div> <div class="fun-date hide" id="fun-date-1"> <p>Year ending on:</p> <div class="custom-select" > <select name="date1" id="date-1"> <option value="2023">2023</option> <option value="2023">2023</option> <option value="2022">2022</option> <option value="2021">2021</option> <option value="2020">2020</option> <option value="2019">2019</option> </select> </div> </div> <div class="fun-date hide" id="fun-date-2"> <p>Year ending on:</p> <div class="custom-select" > <select name="date2" id="date-2"> <option value="2023">2023</option> <option value="2023">2023</option> <option value="2022">2022</option> <option value="2021">2021</option> <option value="2020">2020</option> <option value="2019">2019</option> </select> </div> </div> <div class="fun-date-1 hide" id="fun-date-3"> <p>Year ending on:</p> <div class="custom-select" > <select name="date1" id="q-date"> <option value="Dec 2023">12/2023</option> <option value="Dec 2023">12/2023</option> <option value="Sep 2023">09/2023</option> <option value="Jun 2023">06/2023</option> <option value="Mar 2023">03/2023</option> <option value="Dec 2022">12/2022</option> </select> </div> </div> <div class="fun-date-1 hide" id="fun-date-4"> <p>Year ending on:</p> <div class="custom-select" > <select name="date2" id="a-date"> <option value="Dec 2023">12/2023</option> <option value="Dec 2023">12/2023</option> <option value="Sep 2023">09/2023</option> <option value="Jun 2023">06/2023</option> <option value="Mar 2023">03/2023</option> <option value="Dec 2022">12/2022</option> </select> </div> </div> <input class="fun-btn" type="submit" value="Filter"> </div> </form> <div> <div class="tab-content fundamentals-table"> <!-- income-statement --> <div id="income-statement" class="tab-pane fade in active"> <div> <a href="/sites/default/files/data/alnylam pharmaceuticals, inc.-income-statement-annual.csv" class="icon-text-link"> <span class="icon-wrapper"><img src="/themes/effvision/images/pdf.png" class="icon"></span> <span class="text-link-regular down-link">Download CSV</span> </a> </div> <table class="table table-striped " data-api-url=""> <thead> <th> <span><strong>Note:</strong> Hover over each line item for additional information</span> </th> <th> <span>Year Ending Dec 2023 (Update)</span> </th> <th> <span>Year Ending Dec 2022 (Update)</span> </th> <th> <span>Year Ending Dec 2021 (Update)</span> </th> <th> <span>Year Ending Dec 2020 (Update)</span> </th> </thead> <tbody> <tr class="no-results-row hide"> <td colspan="6" class="no-results-td" style="display: table-cell;"> There are currently no reports available that match your selection. Try using different or fewer filters. <br> If you’re having trouble finding something specific please send an inquiry to <a href="mailto:investors@alnylam.com">investors@alnylam.com</a> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Sales represents sales receipts for products and services, less cash discounts, trade discounts, excise tax, and sales returns and allowances. Revenues are recognized according to applicable accounting principles."> <td data-col-name="title"> <span>Net Sales</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1828.292</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1037.418</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>844.287</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>492.853</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Revenue is used for industrial and utility companies. It consists of revenue from the sale of merchandise, manufactured goods and services, and the distribution of regulated energy resources, depending on a specific company's industry."> <td data-col-name="title"> <span>Revenue</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1828.292</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1037.418</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>844.287</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>492.853</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Revenue represents revenue from all of a company's operating activities after deducting any sales adjustments and their equivalents."> <td data-col-name="title"> <span>Total Revenue</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1828.292</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1037.418</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>844.287</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>492.853</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cost of Revenue includes all costs that can be directly attributable to the goods and services produced/purchased and sold."> <td data-col-name="title"> <span>Cost of Revenue</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>310.406</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>168.817</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>140.144</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>78.052</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cost of Revenue, Total represents total operating expenses directly related to the goods sold and services provided."> <td data-col-name="title"> <span>Cost of Revenue, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>310.406</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>168.817</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>140.144</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>78.052</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Gross Profit represents a measure of a company's operating performance. Gross Profit states the profits earned directly from a company's revenues and direct costs."> <td data-col-name="title"> <span>Gross Profit</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1517.886</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>868.601</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>704.143</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>414.801</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Selling/General/Administrative Expense represents all of the costs of operating a business other than the costs of readying a product for sale. Individual expenses included in Selling/General/Administrative Expense may vary depending on the nature of business of a company, but they cover expenses related to selling and marketing activities, general activities that serve many different departments, and administrative activities."> <td data-col-name="title"> <span>Selling/General/Administrative Expense</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>372.351</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>358.908</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>299.1</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>308.94</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Labor & Related Expense consists of expenses paid to employees of a company in the form of salaries, wages, fees, benefits or any other form of compensation. Labor & Related Expense is collected when it is reported separately from selling, general, and administrative expenses. Expenses paid to auditors and out-sourced consultants need to be excluded from this line unless such labor forces are contracted employees."> <td data-col-name="title"> <span>Labor & Related Expense</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>423.295</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>411.75</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>321.539</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>279.48</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Selling/General/Administrative Expense represents all of the costs of operating a business other than the costs of readying a product for sale. Individual expenses included in Selling/General/Administrative Expense may vary depending on the nature of business of a company, but they cover expenses related to selling and marketing activities, general activities that serve many different departments, and administrative activities."> <td data-col-name="title"> <span>Selling/General/Admin. Expenses, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>795.646</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>770.658</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>620.639</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>588.42</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Research & Development represents expenses for research and development of new products and services by a company in order to obtain a competitive advantage."> <td data-col-name="title"> <span>Research & Development</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1004.415</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>883.015</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>792.156</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>654.819</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Restructuring Charge is an unusual or non-recurring item related to a significant rearrangement of a company's assets and/or liabilities. The restructuring may include discontinuing a line of business, closing plants, or making employee cutbacks. Restructuring Charge is reported as an expense before taxes."> <td data-col-name="title"> <span>Restructuring Charge</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Litigation represents unusual litigation expenses. Litigation expenses may include fees for lawyers, or settlement charges. However, Litigation does not include standard business-related lawyers' fees."> <td data-col-name="title"> <span>Litigation</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Other Unusual Expense (Income)</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>76.586</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Unusual Expense (Income) represents the sum of: Purchased R&D Written-OffRestructuring ChargeLitigationImpairment - Assets Held for UseImpairment - Assets Held for SaleOther Unusual Expense (Income)."> <td data-col-name="title"> <span>Unusual Expense (Income)</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>76.586</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Operating Expense represents the sum of: Industrial Company:Cost of Revenue, TotalSelling/General/Administrative Expenses, TotalDepreciation/AmortizationInterest Expense (Income), Net - OperatingUnusual Expense (Income)Other Operating Expenses, TotalUtility Company:Cost of Revenue, TotalSelling/General/Administrative Expenses, TotalDepreciation/AmortizationInterest Expense (Income), Net - OperatingUnusual Expense (Income)Other Operating Expenses Fuel ExpenseOperations & MaintenanceInsurance Company:Selling/General/Administrative Expenses, TotalDepreciation/AmortizationInterest Expense (Income), Net - OperatingUnusual Expense (Income)Other Operating Expenses, Total."> <td data-col-name="title"> <span>Total Operating Expense</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>2110.467</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1899.076</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1552.939</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1321.291</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Operating Income represents the sum of:Total RevenueTotal Operating Expense."> <td data-col-name="title"> <span>Operating Income</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-282.175</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-861.658</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-708.652</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-828.438</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Interest Expense, Non-Operating represents interest expense on debt of nonfinancial service companies, including insurance companies. The interest expense may be actually paid or imputed on financing transactions. Interest Expense, Non-Operating is always a negative figure."> <td data-col-name="title"> <span>Interest Expense - Non-Operating</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-121.221</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-155.968</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-143.021</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-84.496</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Interest Expense, Net Non-Operating represents Interest Expense, Non-Operating, reduced by Interest Capitalized, Non-Operating, and is usually a negative value."> <td data-col-name="title"> <span>Interest Expense, Net Non-Operating</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-121.221</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-155.968</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-143.021</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-84.496</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Interest Income, Non-Operating represents non-operating interest income, which is generated from non-operating investment securities such as certificates of deposit or bonds for non-financial service companies."> <td data-col-name="title"> <span>Interest Income - Non-Operating</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>95.561</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>24.808</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1.579</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>11.809</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Investment Income, Non-Operating represents income, other than interest, from investment securities. Such income may include dividend income, gain/loss on sale of investment securities, equity earnings in affiliates, unconsolidated subsidiaries or joint ventures (before taxes), or any other investment income."> <td data-col-name="title"> <span>Investment Income - Non-Operating</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-107.941</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-127.971</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>17.262</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Interest/Investment Income, Non-Operating represents the sum of:Interest Income, Non-OperatingInvestment Income, Non-Operating."> <td data-col-name="title"> <span>Interest/Invest Income - Non-Operating</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-12.38</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-103.163</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>18.841</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>11.809</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Interest Income (Expense), Net- Non-Operating, Total represents the sum of:Interest Expense, Net Non-OperatingInterest/Investment Income, Non-OperatingInterest Income (Expense), Net Non-Operating."> <td data-col-name="title"> <span>Interest Inc.(Exp.),Net-Non-Op., Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-133.601</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-259.131</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-124.18</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-72.687</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Non-Operating Income (Expense) represents any non-operating income or expense item that a company reports before taxes that would not be classified as any of the following: Components of Interest Income (Expense), Net Non-OperatingGain/Loss Sale of AssetsUnrealized Gains/LossesMinimum Pension Liability Adjustment."> <td data-col-name="title"> <span>Other Non-Operating Income (Expense)</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-17.741</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-6.204</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-19.312</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>45.525</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other, Net represents the sum of: Unrealized Gains (Losses)Minimum Pension Liability AdjustmentOther Non-Operating Income (Expense)."> <td data-col-name="title"> <span>Other, Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-17.741</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-6.204</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-19.312</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>45.525</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Income Before Tax represents the sum of Operating Income and the following items for all companies other than banks: Interest Income (Expense), Net Non-OperatingGain (Loss) on Sale of AssetsAllowance for Funds Used During Construction - Utility onlyOther, NetFor banks, Net Interest Income After Loan Loss Provision is adjusted by the following items:Non-Interest Income, BankNon-Interest Expense, Bank"> <td data-col-name="title"> <span>Net Income Before Taxes</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-433.517</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1126.993</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.144</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-855.6</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Provision for Income Taxes</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>6.725</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>4.163</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>0.68</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2.681</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Income After Tax represents the sum of Income Tax - Total and Income Before Tax."> <td data-col-name="title"> <span>Net Income After Taxes</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1131.156</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Income Before Extraordinary Items represents net income before being adjusted by extraordinary items, such as: Accounting ChangeDiscontinued OperationsExtraordinary ItemTaxes on Extraordinary Items"> <td data-col-name="title"> <span>Net Income Before Extra. Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1131.156</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Extraordinary Item represents events and transactions that are distinguished by their unusual nature, by the infrequency of their occurrence, and the materiality of their impact on the earnings of the company."> <td data-col-name="title"> <span>Extraordinary Item</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Extraordinary Items represents the sum of: Accounting ChangeDiscontinued OperationsExtraordinary ItemTax on Extraordinary items."> <td data-col-name="title"> <span>Total Extraordinary Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Income represents the sum of Net Income Before Extraordinary Items and Total Extraordinary Items."> <td data-col-name="title"> <span>Net Income</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1131.156</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Income Available to Common Excluding Extraordinary Items represents net income available to common stockholders, not including the effect of extraordinary items, and is used to calculate Basic EPS Excluding Extraordinary Items."> <td data-col-name="title"> <span>Income Available to Com Excl ExtraOrd</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1131.156</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Income Available to Common Stocks Including Extraordinary Items represents net income available to common stockholders, including extraordinary items, and is used to calculate Basic EPS Including Extraordinary Items."> <td data-col-name="title"> <span>Income Available to Com Incl ExtraOrd</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1131.156</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Basic Weighted Average Shares represents the weighted average common shares outstanding less the dilution of stock options for a given period. These shares are used to calculate Basic EPS."> <td data-col-name="title"> <span>Basic Weighted Average Shares</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>124.906</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>121.689</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>118.451</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>114.986</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Basic EPS Excluding Extraordinary Items represents Income Available to Common Excluding Extraordinary Items divided by Basic Weighted Average Shares."> <td data-col-name="title"> <span>Basic EPS Excluding Extraordinary Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-3.52459</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-9.29547</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-7.1998</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-7.46422</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Basic EPS Including Extraordinary Items represents Income Available to Common Stocks Including Extraordinary Items divided byBasic Weighted Average Shares."> <td data-col-name="title"> <span>Basic EPS Including Extraordinary Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-3.52459</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-9.29547</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-7.1998</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-7.46422</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Diluted Net Income represents Net Income adjusted by Dilution Adjustment for Diluted EPS computation. Diluted Net Income assumes the conversion of all convertible preferred stock and debt, which means the net income will be adjusted for not paying out any interest expense or preferred dividends."> <td data-col-name="title"> <span>Diluted Net Income</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1131.156</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Diluted Weighted Average Shares represents the number of shares for Diluted EPS computation. This is used as a denominator for computation of Diluted EPS Excluding Extraordinary Items and Diluted EPS Including Extraordinary Items."> <td data-col-name="title"> <span>Diluted Weighted Average Shares</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>124.906</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>121.689</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>118.451</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>114.986</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Diluted EPS Excluding Extraordinary Items represents Diluted Net Income excluding Total Extraordinary Items and divided by Diluted Weighted Average Shares."> <td data-col-name="title"> <span>Diluted EPS Excluding ExtraOrd Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-3.52459</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-9.29547</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-7.1998</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-7.46422</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Diluted EPS Including Extraordinary Items represents Diluted Net Income divided by Diluted Weighted Average Shares."> <td data-col-name="title"> <span>Diluted EPS Including ExtraOrd Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-3.52459</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-9.29547</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-7.1998</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-7.46422</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="DPS - Common Stock Primary Issue represents dividends paid per share to the primary common shareholders."> <td data-col-name="title"> <span>DPS - Common Stock Primary Issue</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Gross Dividends - Common Stock represents total dividends declared and paid to common shareholders for a period. It represents the gross amount of dividends, before taxes withheld for stockholders."> <td data-col-name="title"> <span>Gross Dividends - Common Stock</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Special Items captures all of the unusual/one-time/special items that impact a company in any given period."> <td data-col-name="title"> <span>Total Special Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>76.586</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Normalized Income Before Taxes represents income before taxes excluding nonrecurring charges and/or credits. It represents the sum of Income Before Tax and Total Special Items."> <td data-col-name="title"> <span>Normalized Income Before Taxes</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-433.517</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1050.407</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.144</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-855.6</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Effect of Special Items on Income Taxes represents the tax effect of non-recurring charges and/or credits."> <td data-col-name="title"> <span>Effect of Special Items on Income Taxes</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>26.8051</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Income Taxes Excluding Impact of Special Items represents the sum of Income Tax - Total and the Effect of Special Items on Income Taxes."> <td data-col-name="title"> <span>Inc Tax Ex Impact of Sp Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>6.725</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>30.9681</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>0.68</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2.681</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Normalized Income After Taxes represents income after taxes excluding nonrecurring charges and/or credits and the related tax effects of excluding the non-recurring charges and/or credits. It is calculated by subtracting Income Taxes Except Impact of Special Items from Normalized Income Before Taxes."> <td data-col-name="title"> <span>Normalized Income After Taxes</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1081.3751</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Normalized Income Available to Common represents the sum of Normalized Income After Taxes and Total Adjustments to Net Income."> <td data-col-name="title"> <span>Normalized Inc. Avail to Com.</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1081.3751</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Basic Normalized EPS represents Normalized Income Available to Common divided by Basic Weighted Average Shares."> <td data-col-name="title"> <span>Basic Normalized EPS</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-3.52459</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-8.88638</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-7.1998</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-7.46422</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Diluted Normalized EPS represents Normalized Income Available to Common adjusted for Dilution Adjustment divided by Diluted Weighted Average Shares."> <td data-col-name="title"> <span>Diluted Normalized EPS</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-3.52459</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-8.88638</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-7.1998</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-7.46422</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Depreciation, Supplemental represents the accounting process of allocating the cost of tangible assets to expenses in a systematic and rational manner to those periods expected to benefit from the use of the assets."> <td data-col-name="title"> <span>Depreciation, Supplemental</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>54.054</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>44.468</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>47.567</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>34.772</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Interest Expense, Supplemental represents interest expense that may be paid and/or imputed, and are reported net of interest capitalized. When interest expense is not reported on the income statement, it is obtained from the notes of the financial statement."> <td data-col-name="title"> <span>Interest Expense, Supplemental</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>121.221</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>155.968</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>143.021</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>84.496</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Rental Expense, Supplemental represents rental expenses paid for offices, factories, machinery and equipment."> <td data-col-name="title"> <span>Rental Expense, Supplemental</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>46.367</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>45.789</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>45.359</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>42.271</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Stock-Based Compensation, Supplemental represents expense related to the adoption of FAS 123(R), ''Share-Based Payment�. Stock-Based Compensation expense is measured at the grant date based on the fair value of the award and is recognized as expense over the employee requisite service period."> <td data-col-name="title"> <span>Stock-Based Compensation, Supplemental</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>221.68</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>230.649</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>165.717</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>139.873</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Equity in Affiliates, Supplemental represents the share of earnings/losses that the company is entitled to from unconsolidated affiliated companies, but that has not been distributed as dividends."> <td data-col-name="title"> <span>Equity in Affiliates, Supplemental</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Research & Development Expense, Supplemental represents expenses for research and development of new products and services by a company in order to obtain a competitive advantage."> <td data-col-name="title"> <span>Research & Development Exp, Supplemental</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1004.415</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>883.015</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>792.156</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>654.819</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Audit Fees, Supplemental comprise of fees for professional services necessary to perform an audit or review in accordance with the standards of the Public Company Accounting Oversight Board, including services rendered for the audit of the Company's annual financial statements (including services incurred with rendering an opinion under Section 404 of the Sarbanes-Oxley Act of 2002) and review of quarterly financial statements."> <td data-col-name="title"> <span>Audit Fees</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>3.4787</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>2.38554</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2.27428</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Audit-Related Fees, Supplemental comprise fees for services that are reasonably related to the performance of the audit or review of the Company's financial statements."> <td data-col-name="title"> <span>Audit-Related Fees</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Tax Fees, Supplemental comprise of fees for tax compliance, tax planning, and tax advice. Corporate tax services encompass a variety of permissible services."> <td data-col-name="title"> <span>Tax Fees</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>0.13</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>0.07</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>0.07</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="All Other Fees Paid to Auditor, Supplemental represents other professional fees paid to the Auditor by the company not classified as: Audit Fees, SupplementalAudit-Related Fees, SupplementalTax Fees, Supplemental."> <td data-col-name="title"> <span>All Other Fees</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>0.00972</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>0.00276</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>0.00276</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Gross Margin represents Gross Profit divided by Revenue."> <td data-col-name="title"> <span>Gross Margin</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>83.02208</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>83.7272</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>83.40091</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>84.16323</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Operating Margin represents Operating Income divided by Total Revenue."> <td data-col-name="title"> <span>Operating Margin</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-15.4338</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-83.05794</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-83.93497</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-168.09028</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Pretax Margin represents Income Before Tax divided by Total Revenue."> <td data-col-name="title"> <span>Pretax Margin</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-23.71158</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-108.63442</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-100.93061</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-173.60146</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Profit Margin represents Income Available to Common Excluding Extraordinary Items divided by Total Revenue."> <td data-col-name="title"> <span>Net Profit Margin</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-24.07941</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-109.0357</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-101.01115</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-174.14543</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Normalized Earnings before Interest and Taxes represents the sum of: Operating IncomeInterest Expense (Income), Net OperatingUnusual Expense (Income)Loss (Gain) on Sale of Assets - Operating."> <td data-col-name="title"> <span>Normalized EBIT</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-282.175</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-785.072</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-708.652</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-828.438</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Normalized Earnings before Interest, Taxes, Depreciation and Amortization represents the sum of: Operating IncomeInterest Expense (Income), Net OperatingUnusual Expense (Income)Loss (Gain) on Sale of Assets - OperatingDepreciation, SupplementalAmortization of Acquisition Costs, SupplementalAmortization of Intangibles, Supplemental."> <td data-col-name="title"> <span>Normalized EBITDA</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-228.121</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-740.604</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-661.085</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-793.666</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Current Tax - Domestic reflects the portion of a company's current income tax provision attributable to its domestic tax jurisdiction."> <td data-col-name="title"> <span>Current Tax - Domestic</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>4.022</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>0.293</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>0.061</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Current Tax - Foreign reflects the portion of a company's current income tax provision attributable to non-domestic tax jurisdictions."> <td data-col-name="title"> <span>Current Tax - Foreign</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>3.416</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>5.596</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3.154</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5.837</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Current Tax - Total reflects the sum of Current Tax - Domestic, Current Tax - Foreign, Current Tax - Local, Current Tax - Other and Current Tax - Total."> <td data-col-name="title"> <span>Current Tax - Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>7.438</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>5.596</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3.447</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5.898</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Deferred Tax - Domestic reflects the portion of a company's deferred income tax provision attributable to its domestic tax jurisdiction. Deferred tax provisions are established to account for changes in deferred tax asset and liability accounts within a given period."> <td data-col-name="title"> <span>Deferred Tax - Domestic</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>0.393</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Deferred Tax - Foreign reflects the portion of a company's deferred income tax provision attributable to non-domestic tax jurisdictions. Deferred tax provisions are established to account for changes in deferred tax asset and liability accounts within a given period."> <td data-col-name="title"> <span>Deferred Tax - Foreign</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-0.713</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1.433</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-2.767</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-3.61</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Deferred Tax - Total reflects the sum of Deferred Tax - Domestic, Deferred Tax - Foreign, Deferred Tax - Local, Deferred Tax - Other and Deferred Tax - Total."> <td data-col-name="title"> <span>Deferred Tax - Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-0.713</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1.433</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-2.767</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-3.217</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Income Tax - Total reflects the sum of Domestic Tax - Other, Foreign Tax - Other, Local Tax - Other and Other Tax."> <td data-col-name="title"> <span>Income Tax - Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>6.725</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>4.163</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>0.68</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2.681</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Other Pension, Net - Foreign</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>4.3</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5.2</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Foreign Pension Plan Expense</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>4.3</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5.2</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Defined Contribution Expense - Domestic represents funds contributed to benefit plans during reported period."> <td data-col-name="title"> <span>Defined Contribution Expense - Domestic</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>17.5</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>16.5</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Pension Expense represents the following: Defined Contribution Expense - DomesticDefined Contribution Expense - ForeignDefined Contribution Expense - Post-Retirement."> <td data-col-name="title"> <span>Total Pension Expense</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>17.5</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>16.5</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>4.3</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5.2</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Total Plan Other Expense</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>4.3</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5.2</span> </td> </tr> </tbody> </table> </div> <div id="balance-sheet" class="tab-pane fade"> <div> <a href="/sites/default/files/data/alnylam pharmaceuticals, inc.-balance-sheet-annual.csv" class="icon-text-link"> <span class="icon-wrapper"><img src="/themes/effvision/images/pdf.png" class="icon"></span> <span class="text-link-regular down-link">Download CSV</span> </a> </div> <table class="table table-striped " data-api-url=""> <thead> <th> <span><strong>Note:</strong> Hover over each line item for additional information</span> </th> <th> <span>Year Ending Dec 2023 (Update)</span> </th> <th> <span>Year Ending Dec 2022 (Update)</span> </th> <th> <span>Year Ending Dec 2021 (Update)</span> </th> <th> <span>Year Ending Dec 2020 (Update)</span> </th> </thead> <tbody> <tr class="no-results-row hide"> <td colspan="6" class="no-results-td" style="display: table-cell;"> There are currently no reports available that match your selection. Try using different or fewer filters. <br> If you’re having trouble finding something specific please send an inquiry to <a href="mailto:investors@alnylam.com">investors@alnylam.com</a> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cash and Equivalents represents short-term, highly liquid investments that are both readily convertible to known amounts of cash and so close to their maturity that they present insignificant risk of changes in interest rates. Only investments with original maturities of three months or less qualify under these definitions. When cash is delineated separately it is classified as Cash, rather than as Cash and Equivalents."> <td data-col-name="title"> <span>Cash & Equivalents</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>812.688</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>866.394</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>819.975</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>496.58</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Short-Term Investments consists of any investments in debt and equity securities with maturity of one year or less. The "short-term" nature depends on actual maturity of one year from the balance sheet date rather than on the original maturity of a specific investment. When a company reports its assets without segregation between current and non-current, all investments are classified as Long-Term Investments - Other."> <td data-col-name="title"> <span>Short Term Investments</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1626.694</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1326.012</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1615.589</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1377.815</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cash and Short-Term Investments is the sum of: CashCash & EquivalentsShort-Term Investments."> <td data-col-name="title"> <span>Cash and Short Term Investments</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>2439.382</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>2192.406</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>2435.564</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1874.395</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Accounts Receivable - Trade, Gross</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>228.211</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>205.621</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>125.305</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>68.871</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Accounts Receivable - Trade, Net represents claims held against customers for goods sold or services rendered as part of normal business operations."> <td data-col-name="title"> <span>Accounts Receivable - Trade, Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>228.211</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>205.621</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>125.305</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>68.871</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Receivables - Other represents a company's receivables that are from activities other than trading (sale of products or services rendered). Non-trading receivables may include both current and non-current receivables; the current portion is classified Receivables - other."> <td data-col-name="title"> <span>Receivables - Other</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>99.576</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>32.342</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>73.266</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>533.542</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Receivables, Net normally represents the sum of: Accounts Receivable - Trade, NetNotes Receivable - Short-TermReceivables - Other."> <td data-col-name="title"> <span>Total Receivables, Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>327.787</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>237.963</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>198.571</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>602.413</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Inventories - Finished Goods represents inventories of unsold finished goods on hand. These goods may have been produced internally or purchased for resale."> <td data-col-name="title"> <span>Inventories - Finished Goods</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>25.123</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Inventories - Work-in-Progress represents inventories of goods in the manufacturing process."> <td data-col-name="title"> <span>Inventories - Work In Progress</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>76.963</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Inventories - Raw Materials represents raw materials acquired, but not yet used. It may also include raw materials in transit. However, Inventories - Raw Materials is limited to materials that will be used for manufacturing of finished goods that will eventually be sold to customers."> <td data-col-name="title"> <span>Inventories - Raw Materials</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>23.346</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Inventories - Other</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-36.286</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>128.962</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>86.363</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>75.202</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Inventory consists of all assets held for sale in the ordinary course of business or goods that will be used and/or consumed in the production of goods to be sold. Inventories may include raw material, work in progress and finished goods, although other categories of asset items may be classified as 'Inventories' depending upon the company's business."> <td data-col-name="title"> <span>Total Inventory</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>89.146</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>128.962</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>86.363</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>75.202</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Prepaid Expenses represents goods or services that have already been purchased, but not fully consumed or used."> <td data-col-name="title"> <span>Prepaid Expenses</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>126.382</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>132.916</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>88.078</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>62.767</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Current Assets is the sum of: Cash and Short Term InvestmentsTotal Receivables, NetTotal InventoryPrepaid ExpensesOther Current Assets, Total."> <td data-col-name="title"> <span>Total Current Assets</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>2982.697</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>2692.247</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>2808.576</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2614.777</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Building - Gross represents the gross amount of buildings and their attachments, before being reduced by accumulated depreciation of the buildings. Building - Gross includes: Properties (residential, commercial, office) for rent in a real estate rental companyLeased property under finance lease, including leasehold improvements on it, for own use."> <td data-col-name="title"> <span>Buildings - Gross</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>507.062</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>500.17</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>414.682</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>412.142</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Land/Improvements - Gross represents land and improvements on land at acquisition cost. Land is not depreciated, but land improvements are normally depreciated over time. It includes Improvements in land (subject to depreciation)."> <td data-col-name="title"> <span>Land/Improvements - Gross</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>9.08</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>9.08</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>9.08</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>9.08</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Machinery/Equipment - Gross represents the acquisition cost of machinery and other equipment (including delivery equipment, office equipment, machinery, furniture and fixtures, furnishings, factory equipment, tools, etc.) in a company, before being reduced by accumulated depreciation."> <td data-col-name="title"> <span>Machinery/Equipment - Gross</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>142.763</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>115.956</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>83.236</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>67.994</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Construction in Progress - Gross represents the cost of construction in progress of fixed assets for a company's own use. The cost of construction in progress is normally not depreciated until the fixed assets are completed and placed in production."> <td data-col-name="title"> <span>Construction in Progress - Gross</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>30.099</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>14.595</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>80.753</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>28.005</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Properties/Plant/Equipment - Gross represents gross property, plant, and equipment, other than those included in the following items: Buildings - GrossLand/Improvements - GrossMachinery/Equipment - GrossConstruction in Progress - GrossLeases - GrossNatural Resources - Gross."> <td data-col-name="title"> <span>Other Property/Plant/Equipment - Gross</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>259.861</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>272.279</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>286.297</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>293.64</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Property/Plant/Equipment, Total - Gross, when fixed assets are reported before depreciation but without detailed delineation, represents the sum of: Buildings - GrossLand/Improvements - GrossMachinery/Equipment - GrossConstruction in Progress - GrossLeases - GrossNatural Resources - GrossOther Property/Plant/Equipment - Gross."> <td data-col-name="title"> <span>Property/Plant/Equipment, Total - Gross</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>948.865</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>912.08</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>874.048</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>810.861</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Accumulated Depreciation, Total represents an aggregate of accumulated depreciation to each of the fixed assets, if any, included in the following items: Buildings - GrossLand/Improvements - GrossMachinery/Equipment - GrossConstruction in Progress - GrossLeases - GrossNatural Resources - GrossOther Property/Plant/Equipment - Gross."> <td data-col-name="title"> <span>Accumulated Depreciation, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-223.076</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-173.45</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-140.415</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-104.347</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Intangibles, Net represents Intangibles, Gross reduced by Accumulated Intangible Amortization. Intangibles, Net is utilized when the company does not provide Intangibles, Gross. Intangibles consist of patents, copyrights, franchises, goodwill, trademarks, trade names, secret processes, and organization costs."> <td data-col-name="title"> <span>Property/Plant/Equipment, Total - Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>725.789</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>738.63</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>733.633</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>706.514</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="LT Investment - Affiliate Companies represents long-term investment in securities (loans, bonds, and equity) of affiliate companies, where the affiliation may be defined as associated companies, joint ventures, and unconsolidated subsidiaries."> <td data-col-name="title"> <span>LT Investment - Affiliate Companies</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Long-Term Investments - Other represents long-term investments with maturities of one year or longer. It also includes special funds such as pension funds."> <td data-col-name="title"> <span>LT Investments - Other</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Long-Term Investments represents the sum of LT Investments - Affiliate Companies and LT Investments - Other."> <td data-col-name="title"> <span>Long Term Investments</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Deferred Income Tax - Long-Term Asset represents credits that are being applied to income taxes that will be paid in future years."> <td data-col-name="title"> <span>Defered Income Tax - Long Term Asset</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Restricted Cash - Long-Term represents cash or cash equivalents that are prepared for specific purposes, subject to long-term restrictions, and not readily available for operational uses. When a company does not delineate between current and non-current assets, all restricted cash is classified as Restricted Cash - Long-Term."> <td data-col-name="title"> <span>Restricted Cash - Long Term</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>51.587</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>49.39</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>40.891</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>40.725</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Long-Term Assets includes: Advances to distributors/officers/employersCash surrenderedCustomer deposits (long-term)Prepaid expenses (long-term)Security deposits (i.e., for renting)Unpaid capital/subscriptions receivable."> <td data-col-name="title"> <span>Other Long Term Assets</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>69.807</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>66.092</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>60.204</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>45.045</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Long-Term Assets, Total represents the sum of: Deferred ChargesPension Benefits - OverfundedDeferred Income Tax - Long-Term AssetDiscontinued Operations - Long-Term AssetRestricted Cash - Long-TermOther Long-Term Assets."> <td data-col-name="title"> <span>Other Long Term Assets, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>121.394</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>115.482</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>101.095</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>85.77</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Assets represents the total assets of a company, which is the sum of: Total Current Assets - Industrial and UtilityCash & Due From Banks - Banking onlyOther Earning Assets, Total - Banking onlyNet Loans - Banking onlyProperty/Plant/Equipment, Total - Net - all industriesGoodwill, Net - all industriesIntangibles, Net - all industriesTotal Utility Plant, Net - Utility onlyLong-Term Investments - all industriesInsurance Receivables - Insurance onlyNotes Receivable - Long-TermIndustrial, Insurance, UtilityOther Long-Term Assets, Total - all industriesDeferred Policy Acquisition Costs - Insurance onlyOther Assets, Total - all industries."> <td data-col-name="title"> <span>Total Assets</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>3829.88</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>3546.359</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3643.304</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>3407.061</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Accounts Payable represents balances owed to suppliers for materials and merchandise acquired on an open account."> <td data-col-name="title"> <span>Accounts Payable</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>55.519</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>98.094</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>73.426</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>51.966</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Accrued Expenses represents operational expenses accrued, but not yet paid. As current liabilities, such expenses are expected to be paid within one year or one operating cycle, whichever is longer."> <td data-col-name="title"> <span>Accrued Expenses</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>754.523</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>587.427</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>435.722</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>392.781</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Notes Payable/Short-Term Debt represents short-term bank borrowings and notes payable that are issued to suppliers."> <td data-col-name="title"> <span>Notes Payable/Short Term Debt</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Income Taxes Payable represents income taxes payable to the government, where such tax liability is already confirmed in terms of amount and payable date. Income Taxes Payable is different from Deferred Income Tax - Current Liability, which is an estimated liability."> <td data-col-name="title"> <span>Customer Advances</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>102.753</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>42.105</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>149.483</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>127.207</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Deferred Income Tax - Current Liability represents income taxes estimated and expected to be paid within one year or an operating cycle, whichever is longer. When liabilities of a company are not delineated between current and non-current, all deferred income tax liabilities are classified in the noncurrent section as Deferred Income Tax - Long Term Liability."> <td data-col-name="title"> <span>Deferred Income Tax - Current Liability</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Current Liabilities represents current liabilities other than: Dividends PayableCustomer AdvancesSecurity DepositsIncome Taxes PayableOther PayablesDeferred Income Tax - Current LiabilityDiscontinued Operations - Current LiabilityWhen liabilities of a company are not delineated between current and non-current, all other liabilities are classified in the non-current section as Other Liabilities."> <td data-col-name="title"> <span>Other Current Liabilities</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>54.991</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>40.289</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>37.079</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>13.316</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Current Liabilities, Total represents the sum of: Dividends PayableCustomer AdvancesSecurity DepositsIncome Taxes PayableOther PayablesDeferred Income Tax - Current LiabilityDiscontinued Operations - Current LiabilityOther Current Liabilities."> <td data-col-name="title"> <span>Other Current liabilities, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>157.744</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>82.394</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>186.562</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>140.523</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Current Liabilities represents current liabilities for industrial and utility companies. Current liabilities are liabilities that are incurred from operating activities and expected to be due within one year or an operating cycle of the company."> <td data-col-name="title"> <span>Total Current Liabilities</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>967.786</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>767.915</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>695.71</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>585.27</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Long-Term Debt represents debt with maturities beyond one year. Long-Term Debt may consist of long-term bank borrowings, bonds, convertible bonds, etc."> <td data-col-name="title"> <span>Long Term Debt</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1020.776</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1016.942</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>675.697</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>191.278</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Long-Term Debt represents the sum of: Long-Term DebtCapital Lease Obligations."> <td data-col-name="title"> <span>Total Long Term Debt</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1020.776</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1016.942</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>675.697</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>191.278</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Debt represents total debt outstanding, which includes: For industrial, insurance, and utility companies:Notes Payable/Short-Term DebtCurrent Portion of Long-Term Debt/Capital LeasesTotal Long-Term Debt.For banks:Total DepositsOther (Interest) Bearing Liabilities, TotalTotal Short-Term BorrowingsCurrent Portion of Long-Term Debt/Capital LeasesTotal Long-Term Debt."> <td data-col-name="title"> <span>Total Debt</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1020.776</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1016.942</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>675.697</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>191.278</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Long-Term Liabilities represents non-interest-bearing long-term liabilities other than: Deferred Income TaxReservesPension Benefits - UnderfundedOther Long-Term Liabilities includes:Liabilities subject to compromiseNegative goodwill (which may be reported as a retained earnings in the shareholders' equity section)."> <td data-col-name="title"> <span>Other Long Term Liabilities</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>2061.962</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1919.725</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1683.694</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1614.266</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Liabilities, Total represents the sum of: ReservesPension Benefits - UnderfundedOther Long-Term LiabilitiesDiscontinued Operations - LiabilitiesOther Liabilities."> <td data-col-name="title"> <span>Other Liabilities, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>2061.962</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1919.725</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1683.694</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1614.266</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Liabilities represents the sum of: For industrial and utility companies:Total Current LiabilitiesTotal Long-Term DebtDeferred Income TaxMinority InterestOther Liabilities, TotalFor banks:Accounts PayablePayable/AccruedAccrued ExpensesTotal DepositsOther (Interest) Bearing Liabilities, TotalTotal Short-Term BorrowingsCurrent Portion of Long Term Debt/Capital LeasesOther Current Liabilities, TotalTotal Long-Term DebtDeferred Income TaxMinority InterestOther Liabilities, TotalFor insurance companies:Accounts PayablePayable/AccruedAccrued ExpensesPolicy LiabilitiesNotes Payable/Short-Term DebtCurrent Portion of Long Term Debt/Capital LeasesOther Current Liabilities, TotalTotal Long-Term DebtDeferred Income TaxMinority InterestOther Liabilities, Total."> <td data-col-name="title"> <span>Total Liabilities</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>4050.524</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>3704.582</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3055.101</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2390.814</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Preferred Stock - Non-Redeemable represents non-redeemable/convertible preferred stock, usually with a fixed amount of dividend. Preferred stock usually has a fixed rate of dividend to the nominal value without any specific maturity. However, most nonredeemable preferred stock has redemption, voting and conversion clauses for certain conditions."> <td data-col-name="title"> <span>Preferred Stock - Non Redeemable</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Preferred Stock - Non-Redeemable, Net represents the sum of: Preferred Stock - Non-RedeemableConvertible Preferred Stock - Non-RedeemableTreasury Stock - PreferredGeneral Partner."> <td data-col-name="title"> <span>Preferred Stock - Non Redeemable, Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Common Stock represents the most frequently issued class of stock; usually it provides a voting right, but is secondary to preferred stock in dividend and liquidation rights. Common stockholders generally control the management of the corporation and tend to profit most if the company is successful, but are guaranteed neither dividends nor assets upon dissolution of their shares."> <td data-col-name="title"> <span>Common Stock</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1.259</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1.24</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1.202</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1.164</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Common Stock, Total represents the sum of Common Stock and Limited Partner, where a company is either a limited partnership or stockholding."> <td data-col-name="title"> <span>Common Stock, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1.259</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1.24</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1.202</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1.164</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Additional Paid-In Capital represents capital contributed by shareholders in excess of par value of common stock in return for shares issued to them."> <td data-col-name="title"> <span>Additional Paid-In Capital</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>6811.063</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>6454.54</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>6058.453</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5644.074</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Retained Earnings (Accumulated Deficit) represents residual earnings from operations, not distributed to shareholders. It may represent accumulated deficit when a company incurs losses over time."> <td data-col-name="title"> <span>Retained Earnings (Accumulated Deficit)</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-7009.591</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-6569.349</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-5438.193</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-4585.369</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Unrealized Gain (Loss)</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-31.244</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-42.262</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-34.422</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-32.444</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Translation Adjustment</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>10.622</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1.3</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3.974</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-7.424</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Minimum Pension Liability Adjustment</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-2.753</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1.092</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-2.811</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-3.754</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Comprehensive Income represents any component of comprehensive income according to SFAS 130 other than: Unrealized Gain (Loss)Cumulative Translation AdjustmentMinimum Pension Liability AdjustmentIt may include any change in equity during a period, except those resulting from investments by owners and distribution to owners."> <td data-col-name="title"> <span>Other Comprehensive Income</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Equity, Total represents the sum of: Cumulative Translation AdjustmentMinimum Pension Liability AdjustmentOther Comprehensive IncomeOther Equity."> <td data-col-name="title"> <span>Other Equity, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>7.869</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-2.392</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1.163</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-11.178</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Equity consists of the equity value of preferred shareholders, general and limited partners, and common shareholders, but does not include minority shareholders' interest."> <td data-col-name="title"> <span>Total Equity</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-220.644</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-158.223</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>588.203</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1016.247</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Liabilities & Shareholders' Equity represents the sum of Total Liabilities and Total Equity."> <td data-col-name="title"> <span>Total Liabilities & Shareholders' Equity</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>3829.88</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>3546.359</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3643.304</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>3407.061</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Shares Outstanding - Common Stock Primary Issue represents the number of common shares outstanding in a company. When a company has two or more different types of common shares outstanding, Shares Outstanding - Common Stock Primary Issue represents the primary issue, which is most actively traded in the market. The description will match the reporting terminology used by the reporting company."> <td data-col-name="title"> <span>Shares Outs - Common Stock Primary Issue</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>125.794</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>123.925</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>120.182</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>116.427</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Common Shares Outstanding represents the number of primary common shares equivalent outstanding. When a company has more than one type of common shares outstanding, the number of shares outstanding for each category is collected and displayed using Shares Outstanding - Common Stock Primary Issue, Shares Outstanding - Common Issue 2, Shares Outstanding - Common Issue 3, and Shares Outstanding - Issue 4. Then, each of issues 2, 3, and 4 is converted to the equivalent of the Primary Issue and are aggregated to derive Total Common Shares Outstanding."> <td data-col-name="title"> <span>Total Common Shares Outstanding</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>125.794</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>123.925</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>120.182</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>116.427</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Treasury Shares - Common Primary Issue represents the number of common shares owned by the company itself and its consolidated subsidiaries. When a company has more than one type of common shares, Treasury Shares - Common Primary Issue represents the number of primary issue shares owned by the company itself or its consolidated subsidiaries. The description will match the reporting terminology used by the reporting company and is related to the corresponding common class of stock."> <td data-col-name="title"> <span>Treas Shares - Common Stock Prmry Issue</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Employees represents the number of full-time employees and full-time equivalents of part-time/temporary employees, as reported, as of the fiscal period end date. Employees includes part-time employees if the company does not differentiate between the two."> <td data-col-name="title"> <span>Full-Time Employees</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>2100</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>2002</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1665</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1453</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Number of Common Shareholders represents the number of common shareholders, as reported, as of the fiscal period end date."> <td data-col-name="title"> <span>Number of Common Shareholders</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>24</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>24</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>24</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>27</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Accumulated Intangible Amortization represents accumulated amortization against intangible fixed assets. Intangible fixed assets are expensed over the useful life of each asset, and amortization of each intangible is included in Accumulated Intangible Amortization. Accumulated Intangible Amortization will be reflected as a positive value."> <td data-col-name="title"> <span>Deferred Revenue - Current</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>102.753</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>42.105</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>149.483</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>127.207</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Deferred Revenue - Current represents advances received from customers for goods or services expected to be delivered within the following fiscal year. Since this revenue is considered 'unearned', a liability for this prepayment is recorded on the balance sheet until delivery of goods or completion of services. In addition to deferred revenues, companies may refer to this item as customer advances, deferred income or unearned revenue/income."> <td data-col-name="title"> <span>Deferred Revenue - Long Term</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>188.175</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>193.791</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>152.36</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>225.094</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Current Assets less Inventory represents Total Current Assets minus Total Inventory. Total Current Assets less Inventory is not available for non-detailed periods or for companies which report non-differentiated balance sheets."> <td data-col-name="title"> <span>Total Current Assets less Inventory</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>2893.551</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>2563.285</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>2722.213</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2539.575</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Quick Ratio represents Total Current Assets less Inventory divided by Total Current Liabilities. Quick Ratio is not available for non-detailed periods or for companies which report non-differentiated balance sheets."> <td data-col-name="title"> <span>Quick Ratio</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>2.98987</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>3.33798</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3.91286</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>4.33915</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Current Ratio represents Total Current Assets divided by Total Current Liabilities. Current Ratio is not available for non-detailed periods or for companies which report non-differentiated balance sheets."> <td data-col-name="title"> <span>Current Ratio</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>3.08198</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>3.50592</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>4.03699</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>4.46764</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Debt represents the sum of: Total DebtMinority InterestRedeemable Preferred StockPreferred Stock - Non Redeemable, Net;LessCashCash & EquivalentsShort Term Investments."> <td data-col-name="title"> <span>Net Debt Incl. Pref.Stock & Min.Interest</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-1418.606</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1175.464</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-1759.867</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-1683.117</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Tangible Book Value represents Total Equity less: Goodwill, NetIntangibles, NetRedeemable Preferred StockPreferred Stock - Non Redeemable, Net."> <td data-col-name="title"> <span>Tangible Book Value, Common Equity</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-220.644</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-158.223</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>588.203</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1016.247</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Tangible Book Value per Share represents Tangible Book Value divided by Total Common Shares Outstanding."> <td data-col-name="title"> <span>Tangible Book Value per Share, Common Eq</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-1.75401</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1.27676</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>4.89427</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>8.72862</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Long Term Debt, Supplemental reflects the sum of Long Term Debt Maturing within 1 through 10 Years and Long Term Debt - Remaining Maturities."> <td data-col-name="title"> <span>Total Long Term Debt, Supplemental</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of long term debt maturing within a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their long term debt maturities in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Long Term Debt Maturing within 1 Year</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of long term debt maturing within a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their long term debt maturities in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Long Term Debt Maturing in Year 2</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of long term debt maturing within a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their long term debt maturities in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Long Term Debt Maturing in Year 3</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of long term debt maturing within a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their long term debt maturities in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Long Term Debt Maturing in Year 4</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of long term debt maturing within a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their long term debt maturities in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Long Term Debt Maturing in Year 5</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Standardized Long Term Debt Maturing in Years 2 and 3 represents the summation of Standardized Long Term Debt Maturing in Year 2 and Standardized Long Term Debt Maturing in Year 3."> <td data-col-name="title"> <span>Long Term Debt Maturing in 2-3 Years</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Standardized Long Term Debt Maturing in Years 4 and 5 represents the summation of Standardized Long Term Debt Maturing in Year 4 and Standardized Long Term Debt Maturing in Year 5."> <td data-col-name="title"> <span>Long Term Debt Maturing in 4-5 Years</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Standardized Long Term Debt Maturing in Year 6 and Beyond represents Total Long Term Debt, Supplemental less Standardized Long Term Debt Maturing within 1 Year, Standardized Long Term Debt Maturing in Year 2, Standardized Long Term Debt Maturing in Year 3, Standardized Long Term Debt Maturing in Year 4 and Standardized Long Term Debt Maturing in Year 5"> <td data-col-name="title"> <span>Long Term Debt Matur. in Year 6 & Beyond</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Total Operating Leases reflects the sum of Operating Leases Maturing within 1 through 10 Years and Operating Leases - Remaining Maturities."> <td data-col-name="title"> <span>Total Operating Leases, Supplemental</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>284.611</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>303.306</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>321.895</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>329.911</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of operating lease payments due in a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their operating lease payments in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Operating Lease Payments Due in Year 1</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>43.587</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>43.028</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>41.783</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>38.593</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of operating lease payments due in a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their operating lease payments in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Operating Lease Payments Due in Year 2</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>46.369</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>46.486</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>47.188</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>46.392</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of operating lease payments due in a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their operating lease payments in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Operating Lease Payments Due in Year 3</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>40.648</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>42.867</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>44.421</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>43.764</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of operating lease payments due in a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their operating lease payments in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Operating Lease Payments Due in Year 4</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>39.006</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>40.376</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>42.936</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>42.918</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="These values represent the amount of operating lease payments due in a specified year following the balance sheet period end date. These values are non-cumulative. If a company presents their operating lease payments in ranges instead of individual years, each range is divided out and the resulting amounts are distributed evenly across the years in the range."> <td data-col-name="title"> <span>Operating Lease Payments Due in Year 5</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>38.358</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>38.753</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>40.246</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>41.19</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Standardized Operating Lease Payments Due in Years 2 and 3 represents the summation of Standardized Operating Lease Payments Due in Year 2 and Standardized Operating Lease Payments Due in Year 3."> <td data-col-name="title"> <span>Operating Lease Pymts. Due in 2-3 Years</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>87.017</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>89.353</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>91.609</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>90.156</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Standardized Operating Lease Payments Due in Years 4 and 5 represents the summation of Standardized Operating Lease Payments Due in Year 4 and Standardized Operating Lease Payments Due in Year 5."> <td data-col-name="title"> <span>Operating Lease Pymts. Due in 4-5 Years</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>77.364</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>79.129</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>83.182</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>84.108</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Standardized Operating Lease Payments Due in Year 6 and Beyond represents Total Operating Leases, Supplemental less Standardized Operating Lease Payments Due within 1 Year, Standardized Operating Lease Payments Due in Year 2, Standardized Operating Lease Payments Due in Year 3, Standardized Operating Lease Payments Due in Year 4 and Standardized Operating Lease Payments Due in Year 5."> <td data-col-name="title"> <span>Oper. Lse. Pymts. Due in Year 6 & Beyond</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>76.643</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>91.796</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>105.321</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>117.054</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Number of Patents represents the number of patents on drug compounds and manufacturing processes held by the company as at the period end."> <td data-col-name="title"> <span>Number of Patents</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Number of Products in Phase I represents the number of products/compounds the company has in Phase 1 clinical trials. Phase 1 clinical trials investigate the safety and proper dose ranges of a product candidate in a small number of human subjects."> <td data-col-name="title"> <span>Number of Products in Phase I</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>5</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>2</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Number of Products in Phase II represents the number of products/compounds the company has in Phase 2 clinical trials. Phase 2 clinical trials investigate side effect profiles and efficacy of a product candidate in a large number of patients who have the disease or condition under study."> <td data-col-name="title"> <span>Number of Products in Phase II</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>6</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>2</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>2</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Number of Products in Phase III represents the number of products/compounds the company has in Phase 3 clinical trials. Phase 3 clinical trials investigate the safety and efficacy of a product candidate in a large number of patients who have the disease or condition under study."> <td data-col-name="title"> <span>Number of Products in Phase III</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>4</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>2</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>3</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Number of Products Launched represents the number of products/compounds that have passed Phase 3 clinical trials, received all necessary regulatory approvals and have been launched for sale for the year."> <td data-col-name="title"> <span>Number of Products Launched</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>3</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5</span> </td> </tr> </tbody> </table> </div> <div id="cash-flow" class="tab-pane fade"> <div> <a href="/sites/default/files/data/alnylam pharmaceuticals, inc.-cash-flow-annual.csv" class="icon-text-link"> <span class="icon-wrapper"><img src="/themes/effvision/images/pdf.png" class="icon"></span> <span class="text-link-regular down-link">Download CSV</span> </a> </div> <table class="table table-striped " data-api-url=""> <thead> <th> <span><strong>Note:</strong> Hover over each line item for additional information</span> </th> <th> <span>Year Ending Dec 2023 (Update)</span> </th> <th> <span>Year Ending Dec 2022 (Update)</span> </th> <th> <span>Year Ending Dec 2021 (Update)</span> </th> <th> <span>Year Ending Dec 2020 (Update)</span> </th> </thead> <tbody> <tr class="no-results-row hide"> <td colspan="6" class="no-results-td" style="display: table-cell;"> There are currently no reports available that match your selection. Try using different or fewer filters. <br> If you’re having trouble finding something specific please send an inquiry to <a href="mailto:investors@alnylam.com">investors@alnylam.com</a> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Income/Starting Line is the first line of a cash flow statement when a company employs the Indirect Method in the operating cash flow section."> <td data-col-name="title"> <span>Net Income/Starting Line</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-440.242</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-1131.156</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-852.824</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-858.281</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Depreciation - Supplemental represents total non-cash depreciation expenses. Depreciation also represents the amount of expense charged against earnings by a company to write off the cost of a plant or machine over its useful life, giving consideration to wear and tear, obsolescence and salvage value."> <td data-col-name="title"> <span>Depreciation</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>54.054</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>44.468</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>47.567</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>34.772</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Depreciation/Depletion represents the sum of Depreciation and Depletion. Depreciation/Depletion is usually the largest non-cash expense factored into net income under the Indirect Cash Flow Method."> <td data-col-name="title"> <span>Depreciation/Depletion</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>54.054</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>44.468</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>47.567</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>34.772</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Unusual Items is applicable only if Net Income/Starting Line is income after gains/losses from unusual activities. Because the operating section of the cash flow pursues changes in cash flow from operating activities, any unusual gain/loss included in net income computation needs to be reversed."> <td data-col-name="title"> <span>Unusual Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>16.944</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>109.898</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-55.695</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-54.042</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Equity in Net Earnings/Loss represents a reversal of non-cash earnings/losses from investments under the Equity Method. For such investments, undistributed earnings/losses of the investee are included in the net income computation of the investor. Since the earnings are non-cash, these are reversed out of cash flow from operations."> <td data-col-name="title"> <span>Equity in Net Earnings (Loss)</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Non-Cash Items represents noncash operating activities other than those included in: Depreciation/DepletionAmortizationDeferred TaxesAccounting ChangeDiscontinued OperationsExtraordinary ItemsUnusual ItemsPurchased R&DEquity in Net Earnings/LossOther Non-Cash Items also includes reversal of gains (losses) on the sale of fixed assets, which is intended to avoid double counting of gains/losses on the sale of noncurrent assets, such as fixed assets, long-term investments in securities, etc."> <td data-col-name="title"> <span>Other Non-Cash Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>462.641</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>471.069</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>382.082</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>275.291</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Non-Cash Items represents the sum of: Accounting ChangeDiscontinued OperationsExtraordinary ItemsUnusual ItemsPurchased R&DEquity in Net Earnings/LossOther Non-Cash Items."> <td data-col-name="title"> <span>Non-Cash Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>479.585</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>580.967</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>326.387</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>221.249</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Accounts Receivables represents changes in accounts receivable during the period. An increase in accounts receivable has a negative impact on cash flow from operating activities, and vice versa."> <td data-col-name="title"> <span>Accounts Receivable</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-87.939</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-45.597</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-101.799</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-56.236</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Inventories represents changes in inventories during the period. An increase in inventories has a negative impact on cash flow from operating activities, and vice versa."> <td data-col-name="title"> <span>Inventories</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>18.367</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-34.136</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-26.415</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-35.426</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Prepaid Expenses represents changes in prepaid expenses during the period. An increase in prepaid expenses has a negative impact on cash flow from operating activities, and vice versa."> <td data-col-name="title"> <span>Prepaid Expenses</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-9.029</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-38.507</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-32.093</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>15.23</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Assets represents changes in other assets during the period. An increase in other assets has a negative impact on cash flow from operating activities, and vice versa."> <td data-col-name="title"> <span>Other Assets</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>5.55</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Accounts Payable represents changes in accounts payable during the period. An increase in accounts payable has a positive impact on cash flow from operating activities, and vice versa."> <td data-col-name="title"> <span>Accounts Payable</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Accrued Expenses represents changes in accrued expenses during the period. An increase in accrued expenses has a positive impact on cash flow from operating activities, and vice versa. When not delineated separately, Accrued Expenses is classified as Accounts Payable/Accrued."> <td data-col-name="title"> <span>Accrued Expenses</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-46.502</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-43.171</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-40.352</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-41.586</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Taxes Payable represents changes in taxes payable during the period. An increase in income taxes payable has a positive impact on cash flow from operating activities, and vice versa."> <td data-col-name="title"> <span>Payable/Accrued</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>80.84</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>191.769</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>88.24</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>143.732</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Liabilities represents changes in other liabilities during the period. An increase in other liabilities has a positive impact on cash flow from operating activities, and vice versa."> <td data-col-name="title"> <span>Other Liabilities</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>55.022</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-65.911</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-50.404</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-43.965</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Changes in Working Capital represents the sum of: Loan Loss Provision (for banks)Accounts Receivable (for insurance companies, industrial companies and utility companies)Prepaid Expenses (for insurance companies and utility companies)Other Assets (for banks, insurance companies and utility companies)Accounts Payable (for insurance companies, industrial companies and utility companies)Accrued Expenses (for insurance companies, industrial companies and utility companies)Payable/Accrued (for banks, insurance companies, industrial companies and utility companies)Taxes Payable (for banks, insurance companies, industrial companies and utility companies)Other Liabilities (for banks, insurance companies, industrial companies and utility companies)Other Assets & Liabilities, Net (for banks, insurance companies, industrial companies and utility companies)Investment Securities, Gains/Losses (for banks and insurance companies)Loans, Gains/Losses (for banks)Other Real Estate Owned (for banks)Sale of Loans (for banks) Loss Adjustment (for insurance companies)Policy Benefits/Liabilities (for insurance companies)Deferred Policy Acquisition Costs (for insurance companies)Policy Refunds (for insurance companies)Reinsurance Receivable (for insurance companies)Reinsurance Payable (for insurance companies)Insurance Reserves (for insurance companies)Unearned Premiums (for insurance companies)"> <td data-col-name="title"> <span>Changes in Working Capital</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>10.759</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-35.553</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-162.823</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-12.701</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cash From Operating Activities represents the sum of: Net Income/Starting LineDepreciation/DepletionAmortizationDeferred TaxesNon-Cash ItemsCash ReceiptsCash PaymentsCash Taxes PaidCash Interest paidChanges in Working Capital."> <td data-col-name="title"> <span>Cash from Operating Activities</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>104.156</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-541.274</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-641.693</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-614.961</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Purchase of Fixed Assets is commonly referred to as Capital Expenditures. Capital Expenditures encompass all expenditures for factories and equipment that have a useful life of more than one year. These expenditures are not treated as an expense on the income statement when they are incurred. Rather, they are capitalized, meaning that they are expensed over time."> <td data-col-name="title"> <span>Purchase of Fixed Assets</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-62.211</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-72.059</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-76.372</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-70.361</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Capital Expenditures represents the sum of: Purchase of Fixed AssetsPurchase/Acquisition of IntangiblesSoftware Development Costs."> <td data-col-name="title"> <span>Capital Expenditures</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-62.211</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-72.059</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-76.372</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-70.361</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Sale/Maturity of Investment represents cash inflow on the sale of securities or repayment of securities matured."> <td data-col-name="title"> <span>Sale/Maturity of Investment</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>1612.275</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>2321.519</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1505.525</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>1691.669</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Purchase of Investments represents cash outflow on the purchase of investments in securities."> <td data-col-name="title"> <span>Purchase of Investments</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-1881.976</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-2075.412</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-1698.255</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-2051.526</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Investing Cash Flow represents investing activities other than the following items: Capital ExpendituresAcquisition of BusinessSale of BusinessSale of Fixed AssetsSale/Maturity of InvestmentPurchase of InvestmentsPrincipal Payments From SecuritiesSale of Intangible AssetsIntangible, NetLoansLoans Origination - InvestingForeclosed Real EstatePolicy LoansOther Investing Cash Flow includes:Long-term advances to related parties (affiliates, unconsolidated subsidiaries, joint ventures, officers, employees, etc.)Cash from the sale of discontinued operationsChanges of cash in escrow/trustInterest/dividends received from investments."> <td data-col-name="title"> <span>Other Investing Cash Flow</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-4.438</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-4.694</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-4.198</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-5.3</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Other Investing Cash Flow Items, Total represents the sum of: Acquisition of BusinessSale of BusinessSale of Fixed AssetsSale/Maturity of InvestmentPurchase of InvestmentsPrincipal Payments From SecuritiesSale of Intangible AssetsIntangible, NetLoansLoans Origination - InvestingForeclosed Real EstatePolicy LoansOther Investing Cash Flow."> <td data-col-name="title"> <span>Other Investing Cash Flow Items, Total</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-274.139</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>241.413</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-196.928</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-365.157</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cash From Investing Activities represents the sum of: Capital ExpendituresOther Investing Cash Flow Items, Total."> <td data-col-name="title"> <span>Cash from Investing Activities</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-336.35</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>169.354</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-273.3</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-435.518</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Other Financing Cash Flow</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>24.667</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>31</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>500.85</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>494.997</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title=" --- "> <td data-col-name="title"> <span>Financing Cash Flow Items</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>24.667</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>31</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>500.85</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>494.997</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Sale/Issuance of Common represents cash inflow from the issuance of common stock. It also includes cash inflow from the sale of treasury shares."> <td data-col-name="title"> <span>Sale/Issuance of Common</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>99.498</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Repurchase/Retirement of Common represents cash outflow on the repurchase of common stock (increase in treasury stock) or the reduction of capital."> <td data-col-name="title"> <span>Repurchase/Retirement of Common</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Common Stock, Net represents the sum of Sales/Issuance of Common and Repurchase/Retirement of Common."> <td data-col-name="title"> <span>Common Stock, Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>99.498</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Options Exercised represents cash inflow due to stock options exercised, which results in an increase of common stock."> <td data-col-name="title"> <span>Options Exercised</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>147.464</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>259.36</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>246.268</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>200.484</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Issuance (Retirement) of Stock, Net represents the sum of: Common Stock, NetPreferred Stock, NetSale/Issuance of Common/PreferredRepurchase/Retirement of Common/PreferredOptions ExercisedWarrants ConvertedTreasury Stock."> <td data-col-name="title"> <span>Issuance (Retirement) of Stock, Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>147.464</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>259.36</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>246.268</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>299.982</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Long Term Debt Issued represents cash inflow on the issuance of long-term debt instruments in a company. Long-term debt may include long-term bank borrowings, corporate bonds, convertible bonds, etc."> <td data-col-name="title"> <span>Long Term Debt Issued</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>1016.111</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>500</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>200</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Long Term Debt Reduction represents cash outflow on the repayment of long-term debt in a company."> <td data-col-name="title"> <span>Long Term Debt Reduction</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-880.718</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Long Term Debt, Net represents the sum of Long Term Debt Issued and Long Term Debt Reduction."> <td data-col-name="title"> <span>Long Term Debt, Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>135.393</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>500</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>200</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Issuance (Retirement) of Debt, Net represents net changes in cash flow due to the changes in the level of debt of a company, which is the sum of: Short Term Debt, NetLong Term Debt, NetTotal Debt IssuedTotal Debt Reduction."> <td data-col-name="title"> <span>Issuance (Retirement) of Debt, Net</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>135.393</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>500</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>200</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cash From Financing Activities represents the sum of: Financing Cash Flow ItemsCash Dividends PaidIssuance (Retirement) of Stock, NetIssuance (Retirement) of Debt, Net."> <td data-col-name="title"> <span>Cash from Financing Activities</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>172.131</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>425.753</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>1247.118</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>994.979</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Foreign Exchange Effects represents the increase/decrease in cash and cash equivalents due to changes in exchange rates."> <td data-col-name="title"> <span>Foreign Exchange Effects</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>6.391</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>-7.43</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>-9.018</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>4.918</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Change in Cash represents the sum of: Cash From Operating ActivitiesCash From Investing ActivitiesCash From Financing ActivitiesForeign Exchange Effects."> <td data-col-name="title"> <span>Net Change in Cash</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>-53.672</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>46.403</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>323.107</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>-50.582</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Cash - Beginning Balance represents the beginning balance of cash and cash equivalents, as defined by a company. This is the ending balance of cash and cash equivalents of the previous fiscal period, with exceptions for certain cases when there are changes in the scope of businesses consolidated. The only situation in which this would vary is the restatement of the cash flow for the previous fiscal period."> <td data-col-name="title"> <span>Net Cash - Beginning Balance</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>868.556</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>822.153</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>499.046</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>549.628</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Net Cash - Ending Balance represents the sum of Net Change in Cash and Net Cash - Beginning Balance. This value will be the ending balance of cash and cash equivalents of the current fiscal period, with exceptions in certain cases where there are changes in the scope of businesses consolidated."> <td data-col-name="title"> <span>Net Cash - Ending Balance</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>814.884</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>868.556</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>822.153</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span>499.046</span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cash Interest Paid represents interest paid in cash during the period. Cash Interest Paid is utilized when the Direct Method is employed for the operating section of the cash flow statement. When a company uses the Indirect Method, this information is classified as Cash Interest Paid and compiled in the supplemental section of the cash flow statement."> <td data-col-name="title"> <span>Cash Interest Paid</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span>32.118</span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span>45.235</span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span>24.657</span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> <tr data-toggle="tooltip" data-placement="top" title="Cash Taxes Paid represents taxes paid in cash. Cash Taxes Paid is utilized when the Direct Method is employed for the cash flow statement. When a company uses the Indirect Method, this information is classified as Cash Taxes Paid and compiled in the supplemental section of the cash flow statement."> <td data-col-name="title"> <span>Cash Taxes Paid</span> </td> <td data-col-name="Year Ending Dec 2023 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2022 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2021 (Update)"> <span> --- </span> </td> <td data-col-name="Year Ending Dec 2020 (Update)"> <span> --- </span> </td> </tr> </tbody> </table> </div> </div> </div> </section> <section class="section clearfix container grey-bgmb-55 pt-65"> <section id="" class="section clearfix final-cards container-970 d-flex flex-1"> <div data-quickedit-field-id="paragraph/82/field_section_paragraphs/en/default" class="field field--name-field-section-paragraphs field--type-entity-reference-revisions field--label-hidden field--items"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><div class="in-card"> <h2 class="in-heading">Related Information</h2> <p class="p-links"><a class="icon-text-link" href="https://www.alnylam.com/alnylam-rnai-pipeline/" target="_blank"><span class="icon-wrapper"><img class="icon" src="/themes/effvision/images/Pipeline.svg" /></span>Our Pipeline ›</a> <a class="icon-text-link" href="/events" target="_blank"><span class="icon-wrapper"><img class="icon" src="/themes/effvision/images/events.svg" /></span>Events & Presentations ›</a> <a class="icon-text-link" href="/press-releases" target=""><span class="icon-wrapper"><img class="icon" src="/themes/effvision/images/press.svg" /></span>Press Releases ›</a> <a class="icon-text-link" href="https://www.alnylam.com/our-science/capella-rnai-innovation/" target="_blank"><span class="icon-wrapper"><img class="icon" src="/themes/effvision/images/capella-icon.svg" /></span>Capella ›</a> <a class="icon-text-link" href="https://www.alnylam.com/our-products/" target="_blank"><span class="icon-wrapper"><img class="icon" src="/themes/effvision/images/group-3.svg" style="width: 32px; height: 32px;" /></span>Our Products ›</a></p> </div> </div> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><div class="in-card"> <h2 class="in-heading">Contact Us</h2> <p class="contact-desc">Looking for specific information that isn't listed above?</p> <span class="card-span">Contact Us:<a class="text-link" href="mailto: investors@alnylam.com">investors@alnylam.com</a> </span></div> </div> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><a href="/alny-stock-information" style="display:block;text-decoration: none;"> <div class="in-card"> <div class="card-exchange"> <h2 class="in-heading"> <span class="exchange"></span> <span class="symbol"></span> </h2> </div> <div class="col symbol-last"> <span class="symbol"></span> <span class="last-trade"></span> </div> <div class="d-flex"> <div class="volume-percent"> <div> <span class="orange">% Change:</span> <span class="change-percent"></span> <div> <span class="orange">Volume:</span> <span class="volume"></span> </div> </div> <div class="number"> <span class="arrow"></span> <span class="change-number"></span> </div> </div> </div> <div class="col date"> <p> Data as of <span class="day"> </span> <span class="time"></span> <br> Copyright Nasdaq. Minimum 15 minutes delay </div> </a></div> </div> </section> </section> </section> </div> </div> <section role="contentinfo" id="footer"> <div class="region region-footer"> <section id="block-signupstaticblock" class="block block-block-content block-block-contenta2ec9cc8-4ca5-4134-a99c-4038b1776642 clearfix"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><section class="new-footer"> <div class="top-dna-lines"> <div class="footer-dna-lines"> <div class="footer-container"> <div class="d-flex"> <div> <h2 class="footer-header">FOLLOW US</h2> <p class="footer-description"> Visit our social channels to learn more about the innovative work we are doing at Alnylam. </p> </div> <div class="right-icons d-flex"> <a target="_blank" href="https://www.youtube.com/channel/UCUZReY0GSAJ1w-MULQb9_Rw" ><img loading="eager" src="/sites/default/files/inline-images/youtube_icon.svg" /></a> <a target="_blank" href="https://www.facebook.com/AlnylamPharma/" ><img loading="eager" src="/sites/default/files/inline-images/fb_icon.svg" /></a> <a target="_blank" href="https://twitter.com/alnylam" ><img loading="eager" src="/sites/default/files/inline-images/x_icon.svg" /></a> <a target="_blank" href="https://www.linkedin.com/company/alnylam-pharmaceuticals/" ><img loading="eager" src="/sites/default/files/inline-images/linkedin_icon.svg" /></a> <a target="_blank" href="https://www.instagram.com/alnylampharma/" ><img loading="eager" src="/sites/default/files/inline-images/instagram_icon.svg" /></a> </div> </div> </div> </div> </div> </section> </div> </section> <section id="block-footer" class="block block-block-content block-block-contentc330350b-d9b5-4ab4-a795-16bcf82a4b29 clearfix"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"><footer> <div class="container-fluid" id="whole-footer-top"> <div class="footer-top"> <div class="row"> <div class="footer-top-column-1 col-sm-3"> <div class="region region-footer-top-column-first"> <nav aria-labelledby="block-footerfirst-menu" id="block-footerfirst" role="navigation"> <h2 class="visually-hidden" id="block-footerfirst-menu">Footer First</h2> <ul class="menu menu--footer-first nav"> <li class="first"><a href="https://www.alnylam.com/about-alnylam/">Our Company</a></li> <li><a href="https://www.alnylam.com/our-science/the-science-of-rnai">Our Science</a></li> <li><a href="https://www.alnylam.com/our-products">Our Products</a></li> <li class="last"><a href="https://news.alnylam.com/">Our News</a></li> </ul> </nav> <nav aria-labelledby="block-footermenu-menu" id="block-footermenu" role="navigation"> <h2 class="visually-hidden" id="block-footermenu-menu">Footer Menu</h2> <ul class="menu menu--footer-menu nav"> <li class="first"><a href="https://alnylampolicies.com/privacy">Privacy Policy</a></li> <li><a href="https://www.alnylam.com/sitemap">Site Map</a></li> <li><a href="https://alnylampolicies.com/legal">Legal Notice</a></li> <li class="last"><a href="https://www.alnylam.com/signup-for-updates/">Sign Up For Updates</a></li> </ul> </nav> </div> </div> <div class="footer-top-column-2 col-sm-3"> <div class="region region-footer-top-column-second"> <nav aria-labelledby="block-footersecond-menu" id="block-footersecond" role="navigation"> <h2 class="visually-hidden" id="block-footersecond-menu">Footer Second</h2> <ul class="menu menu--footer-second nav"> <li class="first"><a href="/">Investors</a></li> <li><a href="https://www.alnylam.com/medical-professional-resources/">Medical Professionals</a></li> <li><a href="https://www.alnylam.com/patients/">Patients</a></li> <li class="last"><a href="https://www.alnylam.com/careers/">Job Seekers</a></li> </ul> </nav> </div> </div> <div class="footer-top-column-3 col-sm-3"> <div class="region region-footer-top-column-third"> <nav aria-labelledby="block-alnylam-footerthirdmenu-menu" id="block-alnylam-footerthirdmenu" role="navigation"> <h2 class="visually-hidden" id="block-alnylam-footerthirdmenu-menu">Footer third menu</h2> <ul class="menu menu--footer-third-menu nav"> <li class="first"><a href="https://www.alnylam.com/alnylam-rnai-pipeline/clinical-trials/">Clinical Trials</a></li> <li><a href="https://www.alnylam.com/about-alnylam/corporate-responsibility/">Corporate Responsibility</a></li> <li><a href="https://www.alnylam.com/about-alnylam/diversity-inclusion/">Diversity, Equity & Inclusion</a></li> <li><a href="/press-releases/">Press Releases</a></li> <li><a href="https://capella.alnylam.com/our-science/capella-rnai-innovation/">Capella</a></li> <li><a href="https://www.rnaiscience.com/" target="_blank">Medical Resources (RNAi Science)</a></li> <li><a href="https://www.alnylam.com/contact-us">Contact Us</a></li> <li><a href="https://www.alnylam.com/signup-for-updates/">Sign Up For Updates</a></li> </ul> </nav> </div> </div> <div class="footer-top-column-4 col-sm-3"> <div class="region region-footer-top-column-fourth"> <nav aria-labelledby="block-alnylam-footerfouthmenu-menu" id="block-alnylam-footerfouthmenu" role="navigation"> <h2 class="visually-hidden" id="block-alnylam-footerfouthmenu-menu">Footer Fouth Menu</h2> <ul class="menu menu--footer-fouth-menu nav"> <li class="first"><a href="https://alnylampolicies.com/privacy">Privacy Policy</a></li> <li><a href="https://www.alnylam.com/media-kit/">Media Kit</a></li> <li><a href="https://alnylampolicies.com/legal">Legal Notice</a></li> <li class="last"><a href="https://www.alnylam.com/sitemap/">Site Map</a></li> </ul> </nav> </div> </div> </div> </div> </div> <div class="container-fluid" id="whole-footer-bottom"> <div class="footer-bottom"> <div class="row"> <div class="footer-bottom-left-area col-sm-6"> <div class="region region-footer-bottom-left"> <section class="block block-block-content block-block-contentf8a60979-5c77-4924-af65-8a03f756d18b clearfix" id="block-alnylam-copyright"> <div class="field field--name-body field--type-text-with-summary field--label-hidden field--item"> <p>Copyright © <span class="timer"> </span> Alnylam Pharmaceuticals, Inc. — All Rights Reserved</p> </div> </section> </div> </div> </div> </div> </div> </footer> </div> </section> </div> </section> </div> <script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"node\/27578","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","suppressDeprecationErrors":true,"bootstrap":{"forms_has_error_value_toggle":1,"modal_animation":1,"modal_backdrop":"true","modal_focus_input":1,"modal_keyboard":1,"modal_select_text":1,"modal_show":1,"modal_size":"","popover_enabled":1,"popover_animation":1,"popover_auto_close":1,"popover_container":"body","popover_content":"","popover_delay":"0","popover_html":0,"popover_placement":"right","popover_selector":"","popover_title":"","popover_trigger":"click","tooltip_enabled":1,"tooltip_animation":1,"tooltip_container":"body","tooltip_delay":"0","tooltip_html":0,"tooltip_placement":"auto left","tooltip_selector":"","tooltip_trigger":"hover"},"user":{"uid":0,"permissionsHash":"b0593a420de843c349377a84aa63f1958f838a820a58657ba0f88fa876cc408a"}}</script> <script src="/core/assets/vendor/jquery/jquery.min.js?v=3.6.0"></script> <script src="/core/assets/vendor/underscore/underscore-min.js?v=1.13.3"></script> <script src="/core/misc/drupalSettingsLoader.js?v=9.4.6"></script> <script src="/core/misc/drupal.js?v=9.4.6"></script> <script src="/core/misc/drupal.init.js?v=9.4.6"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@3.4.1/dist/js/bootstrap.js" integrity="sha256-29KjXnLtx9a95INIGpEvHDiqV/qydH2bBx0xcznuA6I=" crossorigin="anonymous"></script> <script src="/themes/bootstrap/js/drupal.bootstrap.js?sm84ba"></script> <script src="/themes/bootstrap/js/attributes.js?sm84ba"></script> <script src="/themes/bootstrap/js/theme.js?sm84ba"></script> <script src="https://cdnjs.cloudflare.com/ajax/libs/babel-polyfill/7.0.0/polyfill.min.js"></script> <script src="/themes/effvision/js/to_maintain.js?sm84ba"></script> <script src="/themes/effvision/js/select.js?sm84ba"></script> <script src="/themes/effvision/js/sfsmallscreen.js?sm84ba"></script> <script src="/themes/effvision/js/superfish.js?sm84ba"></script> <script src="/themes/effvision/js/script.js?sm84ba"></script> <script src="/modules/custom/alnylam_search/js/alnylam_search.js?sm84ba"></script> <script src="/themes/bootstrap/js/popover.js?sm84ba"></script> <script src="/themes/bootstrap/js/tooltip.js?sm84ba"></script> <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"NRJS-ee2a76a7d3f7daf91d9","applicationID":"434717936","transactionName":"MwADMhFZXkFRW0ReWgpKIAUXUV9cH3xCQkUFCT0IDFxVbnNXXkNHCwkNAxFkfl1UXWZeUBMmDggXSl9eXF1CGgsSDAQR","queueTime":0,"applicationTime":300,"atts":"H0cARFlDTU8=","errorBeacon":"bam.nr-data.net","agent":""}</script></body> </html>